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1) Introduction 
1.1) The structure of the skin 
 
The skin constitutes the largest organ of the body and protects the organism 
against environmental assaults such as UV irradiation, pathogens and 
mechanical stress. Balancing water and electrolyte influx and efflux, the skin 
prevents the body from dehydration. In addition, the skin has thermoregulatory 
and sensory function (Lüllmann-Rauch, 2003).  
Mammalian skin is a complex organ consisting of several layers (Fig. 1). The 
epidermis is the outermost layer creating a barrier against the environment. It 
comprises interfollicular epidermis (IFE) with associated hair follicles (HFs) and 
sebaceous glands (SGs). The underlying dermis provides nutrients to the 
epidermis and stimulates proliferation. The subcutis contains adipocytes and 
serves as nutrient storage for epidermis and dermis (Montagna, 1974b).  
 
 
Fig. 1) The structure of the skin. Epidermis, dermis and subcutis are the three main layers of 
the skin. IFE = interfollilcular epidermis, SG = sebaceous gland, HF = hair follicle. Arrowheads 
point to sebaceous glands. Scale bar = 50 µm.  
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1.2) The interfollicular epidermis 
 
The IFE renews constantly throughout life. Cells originating from the basal layer 
transit the different layers of the epithelium. A tight balance has to be maintained 
between proliferation in the basal layer and cell death in the cornified layer.  
The multilayered stratified epithelium of the IFE is separated from the dermis by 
a basement membrane (Fig. 2). The basement membrane consists of proteins 
secreted by epidermal keratinocytes and dermal fibroblasts (Burgeson and 
Christiano, 1997; McMillan et al., 2003). Undifferentiated, proliferatively active 
keratinocytes are attached to the basement membrane constituting the stratum 
basale (Simpson et al., 2011). Basal keratinocytes express the intermediate 
filaments Keratin (K) 5 and K14. During early postnatal development also K15 
expression can be detected (Liu et al., 2003; Nelson and Sun, 1983). Upon 
terminal differentiation, keratinocytes stop proliferation and detach from the 
basement membrane and are moved into the stratum spinosum (Fig. 2). Keratin 
expression switches from K5 and K14 to K1 and K10 forming a stronger 
intermediate filament network (Fuchs and Green, 1980). Cells of the stratum 
granulosum express further structural proteins like filaggrin and loricrin. These 
are deposited beneath the plasma membrane functioning as scaffold for lipid 
bilayers important for maintaining the barrier function of the IFE (Blanpain and 
Fuchs, 2009; Candi et al., 2005). Finally, cells of the stratum granulosum form 
the outermost layer of the IFE, the stratum corneum (cornified layer). These 
cornified dead cells are eventually shed off.  
 
 
Fig. 2) The interfollicular epidermis. The IFE comprises four different cell layers (stratum 
basale, stratum spinosum, stratum granulosum, stratum corneum).  
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1.3) The hair follicle 
 
The HF (Fig. 3 A) is an appendage of the IFE. In general, it comprises a hair 
shaft and one or two SGs, depending on the type of HF. HFs comprise their own 
stem cell population localised in the permanent part of the follicle in a region 
called bulge.  
The non-permanent part of the HF undergoes cycles of growth (anagen), 
regression (catagen) and rest (telogen) (Lavker et al., 2003; Muller-Rover et al., 
2001) (see 1.3.2 and Fig. 3) and regenerates in a cyclic manner throughout adult 
life (Hardy, 1992).  
Like the IFE, the HF consists of different cellular layers (Fig. 3 B). The outer root 
sheath (ORS) contains proliferating basal keratinocytes. In the so called bulb at 
the lower part of the HF, proliferating transit amplifying cells are localised giving 
rise to cells of the 4 layers of the inner root sheath (IRS) and the 3 layers of the 
hair shaft (Krause and Foitzik, 2006; Rogers, 2004; Schneider et al., 2009). Cell 
type specification of the different cell layers of the IRS and the hair shaft occurs 
at the basis of the HF.  
In mouse pelage fur, four types of HFs exist (Sundberg, 1994). Guard HF make 
up 1-3 % of the mouse fur and produce long tylotrich hairs that have also 
sensory function. Awl hairs constitute about 30 % of the mouse coat and are 
approximately half as long as the guard hairs. The most abundant hair type in 
the mouse coat are zigzag hairs (65 -70%). Zigzag hairs are as long as awl hairs 
but contain up to four bends. Auchene hairs are present at a very low frequency 
in mouse fur (0.1 %). They contain two to four medulla columns (innermost layer 
of the hair shaft) like awl hairs and are bended once resembling zigzag hairs 
(Duverger and Morasso, 2009). 
The HF is formed during embryogenesis and early postnatal development in 
mice (Hardy, 1992).  
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Fig. 3) The hair follicle. A) epidermal whole mount preparation stained with haematoxylin and 
OilRedO; different compartments are shown: B = bulge, HF = hair follicle, HS = hair shaft, JZ = 
junctional zone, SG = sebaceous gland, UI = upper isthmus. B) Different cell layers of the HF, 
IRS = inner root sheath, ORS = outer root sheath, CTS = connective tissue sheath. From 
Schneider et al, 2009.  
 
1.3.1) Morphogenesis of the HF 
 
Morphogenesis of the HF starts during embryonic development around 
embryonic day (E) 14.5 (Duverger and Morasso, 2009). A series of signals 
exchanged between the epidermis and the underlying mesenchyme is preceding 
the formation of HFs (Fuchs, 2007; Hardy, 1992; Millar, 2002). A first 
mesenchymal signals including FGFs and BMP inhibitory factors (Botchkarev et 
al., 1999; Petiot et al., 2003) defines were epidermal thickenings, so called 
placodes are formed. The epidermis emits Wnt signals back to the mesenchyme 
inducing the assembly of dermal cells (dermal condensate) beneath the placode 
(DasGupta and Fuchs, 1999; Gat et al., 1998). The dermal condensate sends a 
second dermal signal to the placode initiating down growth of the epithelium into 
the dermis to form a HF.  
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HF morphogenesis can be sub divided into distinct stages. Each stage describes 
morphological and histological events (Hardy, 1951; Hardy, 1992; Paus et al., 
1999). At stage 0 of HF morphogenesis, no thickening can be seen in the 
epidermis (Fig. 4 A). However, expression of TGFβRII at future sites of HF 
formation can be visualized by immunohistochemistry (Paus et al., 1999). Stage 
1 of HF morphogenesis is marked by condensation of epidermal keratinocytes 
forming a placode (Fig. 4 B). The dermal condensate can be visualized below 
the placode by alkaline phosphatase reaction (see 2.3.5). HFs at stage 2 of 
morphogenesis are clearly distinguishable as an elongation of the epithelium into 
the mesenchyme forming the hair germ (Fig. 4 C). The dermal condensate forms 
a cap like structure below the hair germ. When the HF enters stage 3 of 
morphogenesis, keratinocytes of the lower part enclose the dermal condensate 
forming the dermal papillae (DP) (Fig. 4 D). At stage 4 of HF morphogenesis the 
DP is longer than wide (Fig. 4 E). Above the DP, formation of the IRS starts  (IRS 
cone, Fig. 4 E). HFs at stage 5 of morphogenesis display an elongated IRS and 
melanin granules are visible at the precortex (Fig. 4 F). The DP is almost 
completely enclosed by keratinocytes of the HF. First lipid producing sebocytes 
of the future SG can be visualised by staining with OilRedO. At stage 6 of HF 
morphogenesis, a cluster of sebocytes can be seen at the upper part of the HF 
(Fig. 4 G). The hair canal becomes visible at the transition of the HF and the IFE 
(infundibulum) and a hair shaft is formed within the IRS. In HFs at stage 7 of 
morphogenesis the tip of the hair shaft reaches the hair canal (Fig. 4 H). At the 
last stage of HF morphogenesis (stage 8), the hair shaft emerges through the 
IFE and the HF attains its maximal length.  
In murine back skin, four different types of HFs (1.3) are formed in three distinct 
waves of HF morphogenesis (Duverger and Morasso, 2009). Placodes forming 
guard hairs are first detected at E14.5. Awl and Auchene HFs are induced at 
E16.5 and zigzag HFs are the last to be formed at E18.5. Thus, back skin of 
mice at postnatal (P) 0.5 or P1.5 displays a mixture of HFs at different stages of 
development.  
Once HF morphogenesis is completed, the lower part of the HF enters the cyclic 
renewal and undergoes phases of regression (catagen), rest (telogen) and 
growth (anagen). These phases are tightly controlled by diverse signalling 
events. 
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Fig. 4) Morphogenesis of the HF. (modified from Paus, 1999). A-I) Stage 0 to stage 8 of HF 
morphogenesis. Keratinocytes are marked in grey, dermal fibroblasts are shown in blue and 
sebocytes are depicted in red. IRS = inner root sheath.  
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1.3.2) Cyclic regeneration of the HF  
 
Following morphogenesis, the HF enters the regression phase (catagen) (Fig. 5). 
Cells of the lower portion of the HF undergo apoptosis; the HF shortens aand 
becomes reduced to an epithelial strand. Due to degeneration of the HF, the DP 
is brought in close proximity to the HF bulge. At the end of catagen, a cell 
population called the secondary hair germ (sHG) becomes visible between the 
bulge and the DP (Lyle et al., 1999; Muller-Rover et al., 2001; Panteleyev et al., 
2001).  
Once catagen is completed, the HF remains in a resting phase (telogen) where 
HF stem cells are thought to be quiescent. By the end of telogen, HF stem cells 
become activated by mesenchymal Wnt- and TGFβ-signals from the DP 
(Enshell-Seijffers et al., 2010; Greco et al., 2009; Oshimori and Fuchs, 2012; 
Rendl et al., 2008). It has been shown that cells of the sHG respond faster to 
mesenchymal signals and start proliferation to generate cells for the formation of 
a new HF. With a delay of several days, cells of the bulge become eventually 
activated at the beginning of a new growth phase (anagen) (Greco et al., 2009; 
Hsu et al., 2011; Jaks et al., 2008). During anagen, HF stem cells give rise to 
transit-amplifying cells possessing the ability to undergo a limited number of cell 
divisions. SC progeny moves to the matrix at the basis of the HF to provide cells 
of the different layers of the HF (Fig. 3). Once matrix cells cease to proliferate, a 
new catagen phase starts followed by telogen. With the next anagen phase, the 
hair cycle starts again. 
Clearly, BMP- and Wnt- signalling regulate quiescence and activation of HF stem 
cells. During telogen, active BMP signalling keeps the HF stem cells in a 
quiescent state. The repression of BMP signalling and active Wnt signalling 
leads to activation of HF stem cells (Blanpain et al., 2004; Horsley et al., 2008; 
Kobielak et al., 2007; Rendl et al., 2008). More recently, it has been proposed 
that cells of the DP emit TGFβ2 repressing active BMP signalling and thus, 
leading to activation of sHG cells (Oshimori and Fuchs, 2012). For induction of 
catagen, FGF5 was shown to play a key role (Hebert et al., 1994; Paus and 
Foitzik, 2004; Stenn and Paus, 2001). 
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Fig. 5) The hair cycle. Adult HFs undergo cycles of growth (anagen), regression (catagen) and 
rest (telogen). From Fuchs, 2007.  
 
1.3.3) Stem cells of the HF bulge region  
 
The best characterised HF stem cell compartment is the bulge region located in 
the upper non cycling part of the HF. Bulge stem cells have the ability to retain a 
BrdU label over a long period of time, indicating their slow cycling character 
(label retaining cells, LRC) (Cotsarelis et al., 1990; Lavker et al., 2003; Tumbar 
et al., 2004). Furthermore, several molecules including K15 (Keratin 15), CD34, 
Lhx2 (LIM/homeobox protein2), Sox9 (SRY box9), Tcf3 (T-cell factor3) and 
NFATc1 (Nuclear factor of activated T-cells, cytoplasmic1), have been described 
to be expressed by cells in the bulge region of HFs (Fig. 7) (Horsley et al., 2008; 
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Liu et al., 2003; Lyle et al., 1998; Merrill et al., 2001; Nguyen et al., 2006; Nowak 
et al., 2008; Rhee et al., 2006; Trempus et al., 2003; Vidal et al., 2005). A sub 
population of the telogen bulge and the sHG expresses Lgr5 (leucine-rich repeat-
containing G-protein coupled receptor) (Jaks et al., 2008).  
Bulge stem cells have been isolated by FAC-sorting via CD34+/Igtα6high 
expression. In transplantation assays, the isolated HF stem cells were able to 
regenerate all epidermal lineages, including HF, SG and IFE (Blanpain et al., 
2004). Moreover, it could be demonstrated that HF stem cells contribute to IFE in 
wounding experiments (Ito et al., 2005; Levy et al., 2007).  
Altogether, these studies demonstrate that the bulge region of the HF contains 
multipotent stem cells able to reconstitute all lineages of the epidermis.  
 
1.3.3.1) Lineage tracing of HF bulge stem cells (in K15CreER(G)T2 
mice) 
 
Lineage tracing provides a powerful tool to study the progeny of stem cells within 
a tissue. Therefore, stem cells are labelled with a stable marker that is 
transmitted to the progeny of the originally labelled cell (Kretzschmar and Watt, 
2012).  
During the past years, it was demonstrated by several lineage tracing 
approaches that stem cells of the HF are able to reconstitute HF and the SG 
(Morris et al., 2004; Panteleyev et al., 2000; Petersson et al., 2011; Snippert et 
al., 2010b; Taylor et al., 2000).  
Previously, it had been demonstrated that cells in the HF bulge express K15 
protein (Lloyd et al., 1995; Lyle et al., 1998; Lyle et al., 1999). Moreover, 
expression of the K15 regulatory promoter sequence could be specifically 
localised to the bulge region in adult mice (Liu et al., 2003; Morris et al., 2004). 
To perform lineage tracing of HF bulge stem cells, this promoter region was used 
to drive an inducible Cre recombinase, fused to a modified ligand binding domain 
of the human oestrogen receptor carrying a triple mutation in 
G400V/M543A/L544A (CreER(G)T2) (Forde et al., 2002; Indra et al., 1999; 
Petersson et al., 2011). Upon application of the oestrogen analogue Tamoxifen 
(Tam) cytoplasmic Cre recombinase in K15 positive cells translocates to the 
nucleus and becomes active.  
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K15CreER(G)T2 mice were crossed to R26REYFP-reporter mice (Srinivas et al., 
2001). In these mice, a floxed STOP-cassette is localised ahead of the EYFP- 
(enhanced yellow fluorescent protein) gene within the Rosa26 locus. Cre 
recombinase activity deletes the STOP-cassette leading to constitutive 
expression of EYFP in cells expressing Cre (Fig. 6). As the deletion is 
irreversible, not only the K15 positive cells but also all daughter cells 
constitutively express EYFP. Upon treatment of K15CreER(G)T2/R26REYFP 
mice with a low dose of Tam, individual YFP positive cells can be detected in the 
bulge region of the HF (Petersson et al., 2011). By performing lineage tracing for 
different periods of time, it was demonstrated that cells originating in the HF 
bulge contributed to regeneration of the SG. This occurred independently from 
hair cycling (Petersson et al., 2011).  
Thus, this mouse model constitutes a useful tool to study HF stem cell dynamics 
in adult mouse skin.  
 
 
Fig. 6) K15CreER(G)T2 mouse model. Cre recombinase can be activated in individual bulge 
stem cells upon treatment with Tamoxifen.  
 
1.3.3.2) Expression of bulge stem cell marker Keratin 15 in the skin  
 
K15 expression is not confined to the bulge at all time points during skin 
morphogenesis and homeostasis. It was shown that the K15 promoter fragment 
used for the generation of K15CreER(G)T2/R26REYFP mice was also 
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expressed in cells of the epidermis during neonatal development (Liu et al., 
2003). Expression of LacZ, driven by the K15 promoter, could be detected at 
P2.5 and 3.5 within the epidermis. At P5.5, LacZ expression diminished and was 
no longer detectable in the epidermis by P16.5. However, LacZ expression was 
specifically localised in the bulge region by P16.5 (Liu et al., 2003).  
Interestingly, K15 protein could first be detected at E15.5 in mouse back skin 
(Nöbel, 2009). Detection of K15 protein during embryogenesis indicates that the 
K15 promoter is already active as early as E15.5 and potentially even before in 
mouse back skin. Therefore, K15CreER(G)T2/R26REYFP mice could be used 
for lineage tracing analyses during HF and SG morphogenesis.  
 
 
Fig. 7) Stem and progenitor cell populations of the adult HF. The junctional zone (green), the 
isthmus (blue/dark blue), the bulge region (red) and the secondary hair germ (violet) contain stem 
and progenitor cells implicated in regeneration of the HF and the SG 
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1.3.4) Non-bulge stem and progenitor cell populations of the HF 
 
Besides the bulge, other progenitor compartments have been described during 
the past years (Fig. 7). The HF region above the bulge and below the SG is 
termed upper isthmus. Cells located in this area are recognised by the MTS24-
antibody (mouse thymic stroma24) (Nijhof et al., 2006). Recently, the 
corresponding antigen, Plet1 (placenta-expressed transcript 1 protein), has been 
discovered (Depreter et al., 2008). Cells of the upper isthmus were clonogenic in 
culture and their gene expression profile showed overlap with bulge stem cells 
(Jensen et al., 2008b). Another stem cell population, marked by the expression 
of Lgr6 (leucine-rich repeat-containing G protein-coupled receptor 6) also locates 
to the isthmus region. Lineage tracing showed that these cells were capable of 
regenerating IFE and SG (Snippert et al., 2010b).  
A further stem cell population was described residing in the region next to the 
SG, the so called junctional zone. Cells in this area of the HF express Lrig1. It 
was suggested that Lrig1 positive cells were able to reconstitute IFE and SG 
(Jensen et al., 2009).  
 
1.4) The sebaceous gland 
 
The SG is a holocrine gland mostly attached to HFs (Montagna, 1974a). In skin, 
SGs are generally associated with HFs and localise to the upper, permanent part 
(Schneider et al., 2009). In mouse skin, HFs of different regions of the body 
contain either one or two SGs. In mouse tail skin, two large SGs are attached to 
each HF, whereas most back skin HFs harbour one SG (Duverger and Morasso, 
2009).  
Furthermore, specialised SGs, not associated with HFs, exist. For example 
Meibomian glands in the eyelid have been described (Knop et al., 2009; Knop 
and Knop, 2009; Thody and Shuster, 1989).  
To date, the function of the SG is not completely understood. It is known that 
SGs produce lipids preventing the skin from dehydration and to maintain an 
intact epidermal barrier (Schneider and Paus, 2009; Thody and Shuster, 1989). 
Moreover, analyses of SG deficient (asebia) mouse models have demonstrated 
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that HFs are destroyed in absence of functional SGs (Josefowicz and Hardy, 
1978; Sundberg et al., 2000). This is also observed in human patients with 
scarring alopecia which characteristically start with SG ablation (Sundberg et al., 
2000). These observations suggest that SGs have important function in 
maintenance of the pilosebaceous unit consisting of HF and SG.  
SGs consist of three distinct cellular regions, the peripheral, the maturation and 
the necrosis zone (Fig. 8). Small, proliferatively active cells are located In the 
peripheral zone of the gland (PZ, Fig. 8). These are attached to a basement 
membrane. Constantly, cells from the periphery of the gland are being displaced 
towards the centre of the gland, thereby starting differentiation. Sebocytes of the 
maturation zone (MZ, Fig. 8) produce lipids being stored in the cytoplasm. 
Consequently, the cells increase in size. Once the size reaches a maximum, 
cells of the necrosis zone disintegrate and release their cytoplasmic content (NZ, 
Fig. 8) (Niemann, 2009; Schneider and Paus, 2009; Thiboutot, 2004). The 
mixture of lipids and cellular debris, termed sebum, is transported via the 
sebaceous duct (SD) into the hair canal and to the skin surface (Fig. 8). Sebum 
serves as protection against dehydration and pathogens (Schneider and Paus, 
2009; Thody and Shuster, 1989).  
Several components have been described to play a role in regulating the function 
of the SG. For instance Stearoyl CoA Desaturase 1 (Scd1), an enzyme of the 
fatty acid metabolism, has key functions in maintenance and proper development 
of the gland (Binczek et al., 2007; Miyazaki et al., 2001; Sampath et al., 2009; 
Sundberg et al., 2000; Zheng et al., 1999). Moreover, Scd1 is already expressed 
during early SG development and constitutes a reliable marker for sebocytes 
(Fehrenschild et al., 2012; Frances and Niemann, 2012). Besides Scd1, mature 
sebocytes express MC5R (Melanocortin 5 Receptor) and PPARγ (Peroxisome 
proliferator activator-receptor γ) (Zhang et al., 2006). MC5R influences the 
production and secretion of lipids by sebocytes. Depletion of MCR5 resulted in 
skin barrier defects (Chen et al., 1997). PPARγ stimulates lipid production of 
sebocytes (Rosenfield et al., 1998; Rosenfield et al., 1999). Gene knock-out 
studies suggested that PPARγ is necessary for sebocyte differentiation (Rosen 
et al., 1999).  
The lipids produced by mature sebocytes can be visualised by staining with 
lipophilic dyes such as OilRedO and Nile Red.  
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Fig. 8) The Sebaceous gland (SG). The SG contains a proliferative basal layer (PZ), more 
mature sebocytes in the maturation zone (MZ) and degenerating cells in the necrotic zone (NZ). 
HS = hair shaft. (modified from Schneider and Paus, 2009).  
 
1.4.1) Morphogenesis of the SG 
 
SG morphogenesis occurs in association with HF development. The SG 
develops around P0 as an outgrowth of the ORS of the HF. It has been 
described that first sebocytes are visible at stage 5 of mouse pelage HF 
morphogenesis (Paus et al., 1999). During the first postnatal days, a cluster of 
sebocytes is formed. Around P3 - P4, the glandular structure of the SG, including 
proliferating basal cells surrounding more differentiated cells becomes visible. 
Upon completion of HF morphogenesis, the SG attains its maximal size. 
To date, the molecular mechanisms regulating SG morphogenesis are not clear. 
It has been demonstrated that Sox9 which is necessary for the specification of 
early HF stem cells is also required for SG formation. In absence of Sox9 during 
HF morphogenesis, neither the HF stem cell region nor SGs were formed 
(Nowak et al., 2008). In addition, it was shown in a lineage tracing approach that 
Lgr6 positive cells labelled in hair pegs during HF morphogenesis gave rise to 
cells of the SGs (Snippert et al., 2010b). Moreover, it was proposed that 
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unipotent progenitor cells expressing the transcription factor Blimp1 are located 
at the SD. It was suggested that this cell population is established prior sebocyte 
maturation at the upper developing HF during embryogenesis and early 
postnatal development (Horsley et al., 2006). 
In contrast to the regulation of SG morphogenesis, diverse signalling pathways 
including Wnt and Hedgehog (HH) have been identified playing a crucial role in 
the maintenance and regeneration of the gland in adult mouse skin (Allen et al., 
2003; Merrill et al., 2001; Niemann et al., 2002; Niemann et al., 2003). 
 
1.4.2) Homeostasis and regeneration of the SG 
 
During the past years, several signalling pathways have been shown to be 
implicated in homeostasis and differentiation of the SG. It was demonstrated that 
disturbed Wnt / β-Catenin signalling in basal keratinocytes leads to increased 
differentiation towards the sebocyte lineage (Merrill et al., 2001; Niemann et al., 
2002). C-myc was also shown to be important for proper SG differentiation and 
maintenance. Proliferating cells of normal human skin express c-myc 
(Gandarillas and Watt, 1995; Hurlin et al., 1995). However, over expression of c-
myc in mouse keratinocytes was shown to result in stimulation of sebocyte 
differentiation (Arnold and Watt, 2001; Waikel et al., 2001). Enhanced sebocyte 
differentiation resulting in increased size and number of SGs, was also described 
by over expressing an activated version of the HH receptor smoothened. In 
contrast, inhibition of HH signalling by expressing a dominant negative form of 
the transcription factor Gli2, results in suppression of sebocyte development 
(Allen et al., 2003; Gu and Coulombe, 2008). Furthermore, analyses of the HH 
ligand Indian Hedgehog (IHH) in human and mouse epidermis and sebaceous 
tumours suggested that IHH regulates proliferation and differentiation of 
sebocytes (Niemann et al., 2003).  
To preserve the epidermal barrier function, the cells of the SG constantly 
differentiate and disintegrate generating sebum. To cope with the resulting high 
cellular turn over in the gland, sebocytes need to be replenished. To date, it is 
not fully understood how SGs are regenerated and which cellular compartments 
of the epidermis play a role in this process. Two hypotheses are currently 
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discussed. One assumption is that progenitor cells reside in the gland itself to 
assure the replenishment of cells (Ghazizadeh and Taichman, 2001; Horsley et 
al., 2006). It was proposed that unipotent progenitor cells marked by the 
expression of Blimp1 reside at the sebaceous duct (Horsley et al., 2006). 
However, analyses in human SGs showed that Blimp1 was expressed by more 
mature cells of the SG. Therefore, it is debated if Blimp1 marks SG progenitor 
cells, at least in the human system (Sellheyer and Krahl, 2009).  
Another hypothesis describes multipotent HF stem or progenitor cells that 
migrate upwards and repopulate the SG (Blanpain et al., 2004; Jensen et al., 
2009; Morris et al., 2004; Snippert et al., 2010b; Taylor et al., 2000). Indeed it 
was elegantly shown by lineage tracing analysis following the fate of bulge stem 
cell progeny. It was demonstrated that cells of the bulge region were able to 
regenerate the SG (Petersson et al., 2011) (see 1.3.3.1). 
 
1.5) Impaired Wnt / β-Catenin signalling leads to skin tumour 
formation  
1.5.1) Canonical Wnt signalling  
 
A central component of the canonical Wnt / β-Catenin signalling pathway is β-
Catenin. Within the cell, β-Catenin is either localised in the cytoplasm or 
associated with the members of the cadherin family in the adherens junctions of 
the cell membrane (Huber et al., 1997; Huelsken et al., 1994). Nuclear 
localisation of β-Catenin is a sign of active Wnt-signalling (Nusse, 2005).  
In the absence of the Wnt ligand, cytoplasmic β-Catenin is phosphorylated and 
targeted for proteasomal degradation by a protein complex comprising Axin1, 
APC, CK1-α and GSK3β (Fig. 9). If a Wnt ligand is present and binds to the 
receptor frizzled and its coreceptor LRP, dishevelled gets activated and recruits 
the degradation complex to the membrane by interacting with Axin1. As a 
consequence, β-Catenin cannot be phosphorylated and is not targeted for 
proteasomal degradation. Stabilised β-Catenin accumulates in the cytoplasm 
and eventually translocates into the nucleus. Here, β-Catenin can bind to 
members of the transcription factor family TCF/Lef, displacing transcriptional 
repressors like Groucho or CBP. The β-Catenin-TCF/Lef complex acts as a 
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transcriptional activator. Upon binding of β-Catenin to TCF/Lef transcription 
factors, target genes like c-Myc, Cyclin-D1 and E-Cadherin are expressed 
(Clevers, 2006; Nusse, 2005).  
Besides Wnt-ligands, other molecules can activate the pathway. For example R-
spondin was shown to potentiate Wnt-signalling (Kazanskaya et al., 2004; Kim et 
al., 2008). However, it remained unclear which receptor was implicated in active 
Wnt signalling mediated by R-spondin. Recently, it was shown that R-spondin 
can bind to Lgr5, Lgr6 and Lgr4 (Carmon et al., 2012; de Lau et al., 2011; Glinka 
et al., 2011). This family of molecules marks stem cells in different tissues 
including skin (Barker et al., 2007; Barker et al., 2010; Jaks et al., 2008; Snippert 
et al., 2010b). Lgr4 and Lgr5 associate with frizzled/LRP receptor complexes, 
upon binding of R-spondin, Wnt signalling is enhanced.  
 
 
Fig. 9) The canonical Wnt-signalling pathway. Upon binding of Wnt-ligand to the receptor 
complex formed by frizzled and LRP, cytoplasmic β-Catenin is stabilized, translocates to the 
nucleus and can activate target gene transcription (ON). In absence of Wnt, β-Catenin is 
phosphorylated and targeted for degradation (OFF).  
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1.5.2) Impact of Wnt / β-Catenin signalling in skin 
 
Wnt / β-Catenin signalling in the skin has been shown to have crucial functions in 
morphogenesis of the HF (Andl et al., 2002). In absence of canonical Wnt 
signalling, placode formation is blocked (Huelsken et al., 2001). In contrast, 
forced expression of stabilized β-Catenin, resulting in enhanced Wnt signalling, 
leads to precocious and increased HF placode formation (Narhi et al., 2008; 
Zhang et al., 2008).  
In adult skin, Wnt / β-Catenin signalling is needed to activate stem cells of the HF 
bulge region to start a new anagen phase after telogen (Lowry et al., 2005; 
Stenn and Paus, 2001). Moreover, forced expression of β-Catenin in the 
epidermis resulted in de novo HF formation (Gat et al., 1998; Lo Celso et al., 
2004). Also, canonical Wnt signalling is required for proper hair cycling. 
Inactivation of β-Catenin in the DP resulted in premature catagen and disturbed 
HF regeneration (Enshell-Seijffers et al., 2010). Expression of stabilised β-
Catenin in the epidermis leads to precocious induction of anagen (Lo Celso et 
al., 2004; Lowry et al., 2005; Van Mater et al., 2003).  
Furthermore, aberrant Wnt signalling is associated with skin cancer 
development. Activating mutations of β-Catenin lead to formation of HF tumours 
(Gat et al., 1998; Lo Celso et al., 2004). Blocking of Wnt / β-Catenin signalling in 
epidermal cells promotes sebaceous cell fate and squamous differentiation 
(Merrill et al., 2001; Niemann et al., 2002). Moreover, activating mutations in the 
β-Catenin gene and inactivating mutations of the transcription factor Lef1 
(lymphoid enhancer factor1) are present in human skin tumours (Chan et al., 
1999; Takeda et al., 2006) 
 
1.5.3) K14∆NLef1 mouse model 
 
To analyse the function of Wnt / β-Catenin signalling in the skin in more detail, a 
transgenic mouse model displaying inhibited Lef1 mediated β-Catenin signalling 
in the epidermis was generated (K14∆NLef1 mice) (Niemann et al., 2002). In 
these mice, an N-terminally truncated version of the transcription factor Lef1 is 
expressed in the epidermis. The N-terminus of the Lef1 transcription factor 
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contains the binding site for β-Catenin. As the binding domain is lacking in 
K14∆NLef1 mice, β-Catenin can no longer bind to Lef1 and fails to form a 
transcriptional activator. Target gene expression is therefore repressed. The 
mutated transcription factor Lef1 is expressed under the control of the K14 
promoter. Thus, all basal cells of the IFE, HF and SG express mutant Lef1 and 
display inhibited Wnt signalling.  
K14∆NLef1 mice show severe hair loss starting by the age of six weeks. 
Moreover, epithelial cysts derived from HFs are formed and ectopic SG formation 
along the HF is detected. At about three months of age, K14∆NLef1 mice 
developed spontaneous benign sebaceous adenomas and sebeomas (Niemann 
et al., 2002). Sebaceous tumour formation can also be induced by performing a 
chemical carcinogenesis experiment with K14∆NLef1 mice. It was demonstrated 
that mutated Lef1 acted as a tumour promoter and specified the type of the 
developing tumours (Niemann et al., 2007).  
 
1.5.4) K14∆NLef1/L61Rac1 double transgenic mice 
 
Previously, it had been reported that the small GTPase Rac1 plays an important 
role in maintaining stem cells properties in epidermal cells. Upon deletion of 
Rac1, epidermal stem cells divided more frequently and underwent terminal 
differentiation. Activation of Rac1 lead to an expansion of the cell population 
capable of clonal growth (Benitah et al., 2005). 
By crossing L61Rac1 into the background of K14∆NLef1-mice, the effect of 
active Rac1 on tumour growth, histology and invasiveness in benign tumours 
should be addressed. Another important aspect to analyse was the potential 
expansion of progenitor compartments as described by Benitah and colleagues 
(Benitah et al, 2005). 
K14∆NLef1 mice were crossed to mice expressing constitutively active Rac1 
(L61Rac1 transgenic mice (Behrendt et al., 2012; Stachelscheid et al., 2008; 
Tscharntke, 2006). Double transgenic mice (K14∆NLef1/L61Rac1-mice) did not 
show obvious histological differences to K14∆NLef1 mice regarding normal skin. 
Mice that were subjected to a one-step carcinogenesis experiment developed a 
comparable number of tumours as K14∆NLef1 control mice (Tscharntke, 2006). 
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1.6) Aims 
 
HF and SG are two integral parts of the pilosebaceous unit of mammalian 
epidermis and contribute to formation of an intact epidermal barrier. Progress 
has been made in our understanding of HF morphogenesis and regeneration. In 
addition to the stem cells of the HF bulge region, other stem and progenitor 
compartments have been identified within the HF. However, it is not known when 
these stem and progenitor cell compartments are established and when they first 
become activated for tissue formation and regeneration.  
Recently, it has been demonstrated that stem cells of the HF bulge region play a 
role in the process of SG regeneration in adult skin. In contrast, hardly anything 
is known about the cellular mechanisms involved in SG development. 
Therefore, one aim of this thesis is to identify spatio-temporal distribution of HF 
stem and progenitor cell compartments during SG morphogenesis in neonatal 
mouse skin. We want to determine the cellular mechanisms of SG 
morphogenesis in more detail and to identify the stem cell population giving rise 
to sebocytes. Furthermore, to investigate the origin of cells forming the SG, 
lineage tracing experiments are performed during morphogenesis.  
 
In addition, during adult skin homeostasis, the small GTPase Rac1 is important 
for maintenance of the HF stem cell compartment. Activation of Rac1 leads to an 
expansion of cells capable of clonal growth. To address the role of active Rac1 in 
SG cell differentiation and skin tumour formation, constitutively active Rac1 was 
expressed in benign sebaceous skin tumours. From these experiments, we want 
to get insight into the role of Rac1 in skin tumour formation, differentiation and 
progression. Therefore, histology and expression of skin stem cell and 
differentiation markers will be analysed in skin tumours. To understand the 
potential role of Rac1 in regulating important aspects of progenitor commitment, 
proliferation and differentiation, gene expression profiles of distinct tumour cell 
populations will be analysed.  
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2) Material and Methods 
2.1) Chemicals and reagents 
2.1.1) Chemicals 
 
Table 1) Chemicals 
Reagent Company 
Adenine 
Sigma, Germany 
Agarose 
Bovine Serum Albumine (BSA) 
BrdU 
Cholera enterotoxin 
Crystal violet 
DAPI 
DEPC 
Dithiothreitol (DTT) 
EGF 
Fish skin gelatine (FSG) 
Formamid 
Glutaraldehyde 
Hydrocortisone 
Igepal 
Insulin 
K2HPO4 
MgCl2 
Mineral oil 
Mitomycin C 
Normal donkey serum (NDS) 
Nuclear fast red 
Normal goat serum (NGS) 
Propidium iodide (PI) 
Proteinase K 
Rabbit serum (RS) 
Sunflower oil 
Tamoxifen  
Thermolysin 
Triton X 100 
Acetone 
Roth, Germany 
EDTA 
Ethanol (EtOH) 
Formaldehyde 
HEPES 
Methanol (MeOH) 
NacL 
Tris 
Xylol 
2-propanol 
DMEM/HAMsF12-medium 
Biochrom, Germany PBS (10x) Penicillin/Streptomycin 
Glutamine 
dNTPs 
Roche, Germany NBT/BCIP 
tRNA 
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Mayer’s Heamatoxylin 
Merck, Germany Kayser glycerol gelatine 
Paraformaldehyde 
Eosin AppliChem, Germany Tween-20 
FCS PAA, Germany FCS Gold 
mTRAP buffer 
Active Motif, Belgium protease Streptavidin beads 
PNA 
Citrate buffer BioGenex, Germany 
OilRedO Amresco 
OCT Sakura, Germany 
Pertex Leica, Germany 
low range marker Fermentas, Germany 
EdU Invitrogen, Germany 
“Ready to load” enzyme mix BioBudget, Germany 
chelex Biorad, Germany 
DMEM GIBCO, Germany 
Milk powder Heirler 
TdT USB 
Betaisodona Mundipharma, Germany
 
2.1.2) Solutions and buffers 
 
Table 2) Solutions and buffers 
Solution Composition 
10x TAE buffer 
0.9 M Tris Ultra 
0.89 M Boric acid 
20 mM EDTA 
1x TAE buffer 100 ml 10x TAE buffer 900 ml dH2O 
DMEM / HAMs F12 medium  
supplemented with 
100 IU/ml penicillin 
100 µg/ml streptomycin 
1.8 x 10-4 M adenine 
0.5 g/ml hydrocortison 
10 ng/ml EGF 
10-5 M cholera toxin 
5 µg/ml insulin 
10 % FCS (chelex-100 resin treated) 
Lysis buffer 
0.2 M NaCl 
0.1 M Tris HCl pH 8,5 
5 UM EDTA 
0.2% SDS 
8.4 ml dH2O 
add 5 Ul Proteinase K (20mg/ml) before
use 
Mowiol/DABKO 
4.8 g Mowiol 
12 g Glycerin 
12 ml H2O 
stirr 3 - 4 h 
add 24 ml 0.2 M Tris pH 8 
heat to 50 °C and stir overnight 
add 1.2 g DABKO (2,5%) 
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2.1.3) Antibodies 
 
The primary antibodies used in this study are listed in Table 3; secondary 
antibodies are listed in Table 4.  
 
Table 3) Primary antibodies 
antigen host dilution reference / company 
Adipophilin guinipig 1:3000 Fitzgerald Industries 
BrdU mouse 1:10 (sections) BD 
BrdU rat 1:500 Oxford Biotech 
CD49f-PE 
(Itgα6) rat 1:25 BD 
GFP chicken 1:3000 / 1:5000 (K14NuMA-GFP sections) Abcam 
GFP-488 goat 1:500 Rockland 
K14 rabbit 1:3000 Covance 
Laminin rabbit 1:100 Sigma 
Lrig1 goat 1:100 / 1:50 (K14NuMA-GFP sections) R&D Systems 
MTS24 rat 1:50 (Gill et al., 2002) 
P-Cadherin goat 1:250 R&D Systems 
Plet1 rat 1:3 (Raymond et al., 2010) 
Scd1 goat 1:150 Santa Cruz 
Scd1 rat 1:150 R&D Systems 
Sox9 rabbit 1:3000 (Stolt et al., 2003) 
 
Table 4) Secondary antibodies 
species conjugate dilution reference / company 
Anti-chicken Alexa488 1:500 Molecular Probes 
Anti-goat Alexa488, Alexa594, Cy5 1:500 Molecular Probes 
Anti-guinipig Alexa488 1:500 Molecular Probes 
Anti-mouse (IgG1) Alexa488 1:1000 Molecular Probes 
Anti-rat Alexa594, Cy5 1:400 Molecular Probes 
Anti-rabbit Alexa488, Alexa594, Cy5 1:500 Molecular Probes 
Anti-rabbit HRP 1:500 DAKO 
HRP = horseradish peroxidase 
2.1.4) Kits 
 
Table 5) Kits 
Kit Company 
Click-It EdU Kit Invitrogen, Germany
Expand Long Template Roche, Germany 
Quanti Tect Reverse Transcriptase Qiagen, Germany 
RT2RT SYBR Green qPCR Master MIx Super Array 
Super Script II First Strand Synthesis Invitrogen, GermanySuper Script III First Strand Synthesis 
TaqMan gene expression assay Applied Biosystems 
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2.2) Mouse experiments 
 
All experiments conducted with mice have been performed according to 
institutional guidelines and animal license given by the State Office of North 
Rhine-Westphalia, Germany.  
The used mouse strains were kept on a C57Bl/6 background.  
 
2.2.1) Mouse models 
 
Table 6 summarises the transgenic mouse models used in this study. In addition, 
C57Bl/6-mice were applied for most of the experiments.  
 
Table 6) Mouse models applied in this study 
Mouse model reference 
K15CreER(T2)/R26REYFP (Petersson et al., 2011; Srinivas et al., 2001) 
K14∆NLef1 (Niemann et al., 2002) 
K14L61Rac1 (Behrendt et al., 2012; Stachelscheid et al., 2008; Tscharntke, 2006)  
K14NuMAGFP (Poulson and Lechler, 2010) 
 
2.2.2) Activation of Cre recombinase 
 
A single dose of Tamoxifen was injected intraperitoneally (i.p.) into the mice. 
Therefore, 1 mg or 2 mg Tamoxifen (Sigma Aldrich) powder was dissolved in 
200 µl sun flower oil (Sigma Aldrich) by robust shaking for 1 h at room 
temperature (Indra et al., 1999). AK15CreER(T2)/R26REYFP-mice received 2 
mg of Tamoxifen and mice from the higher expressing 
CK15CreER(T2)/R26REYFP line were treated with 1 mg Tamoxifen. Tamoxifen 
is an oestrogen analogue. It is used to activate Cre recombinase fused to a 
modified oestrogen receptor. Cre normally located in the cytoplasm can 
translocate into the nucleus and becomes activated. In both mouse lines, 
activated Cre recombinase leads to the excision of a stop-cassette in front of the 
EYFP-gene (Fig. 8). Therefore, EYFP can be expressed in all cells with activated 
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Cre recombinase. As the excision of the stop-cassette is irreversible, all daughter 
cells also express the EYFP-gene.  
 
2.2.3) BrdU / EdU injections 
 
To mark proliferating cells within the tissue, mice were injected i.p. with 5-bromo-
2'-deoxyuridine (BrdU, Sigma Aldrich, Germany) or 5-ethynyl-2’-deoxyuridine 
(EdU, Invitrogen, Germany) 1 – 48 h before sacrificing them. BrdU and EdU are 
base analogues that are incorporated in DNA of dividing cells. 
BrdU was used at a concentration of 100 mg/kg bodyweight; EdU was used at a 
concentration of 40 mg/kg bodyweight.  
EdU-incorporation was monitored using the Click-it EdU kit following the 
manufacturer’s instructions (Invitrogen, Germany). BrdU-incorporation was 
analysed by antibody staining (see 2.3.3).  
 
2.2.4) Tissue preparation 
 
To analyse HF and SG morphogenesis, skin tissue was prepared from mice 
between E15.5 and P30. In general, back and tail skin was prepared following 
the protocols described below.  
 
2.2.4.1) Tissue preparation for paraffin and cryo embedding 
 
Mice were sacrificed and the skin was prepared as described before (Paus et al., 
1999). Briefly, back skin was isolated and stretched out on thick paper. Small 
pieces (about 0.5 cm2) of skin were cut along the longitudinal axis of the HFs. 
For tail skin preparation, the tail was cut off the mouse. The tail was sliced open 
on the ventral side; skin was peeled of the bone and stretched out on thick 
paper. 
Before paraffin embedding, the tissue was fixed for 2h with 4% Formalin/PBS 
and removed from the paper.  
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For cryo embedding of skin pieces, the tissue was prepared as described above. 
Unfixed tissue was embedded in OCT (Sakura), allowed to freeze slowly in cold 
isopentane and stored at –80°C. 
 
2.2.4.2) Preparation of epidermal whole mounts 
 
For three-dimensional analysis of the epidermis, whole mounts of mouse 
epidermis were generated as described before (Braun et al., 2003). Briefly, tail 
skin was prepared (2.2.4.1) and incubated in 5 mM EDTA at 37°C to allow 
separation of the epidermis from the underlying dermis. Skin of newborn mice 
was incubated for 1.5 h whereas skin of adult mice was incubated for up to 3 h. 
To prepare epidermal whole mount samples from back skin, the tissue was 
incubated for 2 h in 20 mM EDTA and separated from the dermis. Epidermal 
whole mounts were fixed for 1 h in 3.4 % Formaldehyde or 0.2 % glutaraldehyde/ 
2 % formaldehyde and kept in PBS at 4°C.  
 
2.3) Tissue analysis and histology 
2.3.1) Deparaffinisation 
 
Sections of paraffin embedded tissue were deparaffinised before proceeding with 
stainings. Therefore, sections were incubated two times for 10 min in 100 % 
Xylol (Roth, Germany). Next, sections were kept two times for 5 min in 100% 
EtOH (Roth, Germany) followed by incubation in 95 %, 70 % and 50 % EtOH for 
5 min respectively. Before proceeding with the staining protocols, the sections 
were incubated for 5 min in tab water followed by 5 min in distilled water to wash 
out residues of EtOH.  
 
2.3.2) Haematoxylin and eosin staining 
 
To visualize the histology of skin sections, deparaffinised sections were stained 
with haematoxylin and eosin. For nuclear staining, sections were incubated for 1-
3 min in haematoxylin (Merck, Germany) followed by tab water to develop the 
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staining. After brief washing in distilled water, sections were briefly counter 
stained with eosin (AppliChem, Germany) to visualise the cytoplasm of the cells. 
Next, the sections were incubated shortly in 70 % and 95 % EtOH followed by 
incubation in 100 % 2-propanol and 100 % xylol. The sections were finally 
mounted with Pertex (Leica, Germany). Analysis and imaging of the staining was 
performed with a Leica DM4000B microscope (Leica Mikrosysteme GmbH, 
Wetzlar) supplied with a KY-F75U digital-camera (JVC Professional Europe Ltd., 
Frankfurt). 
 
2.3.3) Immunofluorescence stainings 
 
Immunofluorescence stainings were performed on paraffin or cryo sections of 
mouse skin or on epidermal whole mounts. Nuclear staining was performed for 
30 min at room temperature with DAPI (Sigma, Germany) at a concentration of 
1µg/ml. Imaging of all immunofluorescence stainings was performed by confocal 
microscopy (Olympus IX80) supplied with an Olympus LG ESF200 camera 
unless specified differently.  
 
2.3.3.1) Immunofluorescence stainings of epidermal whole mounts 
 
Epidermal whole mounts were blocked in TB buffer containing 0.5 % milk 
powder, 0.25 % FSG and 0.5 % TritonX-100 in TBS (20 mM HEPES, pH7.2, 0.9 
% NaCl) (Braun et al., 2003). Primary antibodies were diluted in TB buffer and 
incubated over night at room temperature. Washing steps to remove antibody 
residues were carried out with 0.02 % Tween (AppliChem, Germany) in PBS. 
Secondary antibodies diluted in TB buffer were incubated for 3 h up to overnight. 
The dilutions of the antibodies applied are listed in Table 3 and 4.  
 
2.3.3.2) Immunofluorescence stainings of paraffin sections 
 
Paraffin sections were deparaffinised and rehydrated before proceeding with 
antibody staining (2.3.1). The antibodies used are listed in Table 3 and 4. For 
staining of tumour tissue, the sections were incubated in citrate buffer 
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(BioGenex, USA) for 20 min at < 120°C under pressure in the 2100 Retriever 
(Proteogenix, France) to unmask the antigens. After washing with PBS, sections 
were incubated in blocking solution (10% RS (Sigma, Germany) in PBS) for 1 h 
at room temperature. Primary antibodies were incubated over night at 4°C. 
Secondary antibodies were incubated for 30 min at room temperature. After each 
antibody incubation step, washing was performed 3 times for 5 min with PBS. 
Sections were mounted with Mowiol/DABKO.  
 
2.3.3.3) Immunofluorescence stainings of cryo sections 
 
Sections of frozen tissue from K14NuMA-GFP mice (7-10 µm) were fixed in 4 % 
PFA or acetone before proceeding with antibody stainings except for staining 
with Scd1. Here, fixation was carried out after Scd1 staining was done. Dilutions 
of the used antibodies are listed in Table 3 and 4; blocking solutions are 
specified in Table 7. Primary antibodies were incubated over night at 4°C. The 
primary antibody against GFP was incubated for 15 min at room temperature. 
Secondary antibodies were incubated for 30 min at room temperature. Washing 
was carried out with PBS thrice for 5 min after each antibody incubation step. 
Sections were mounted with Mowiol/DABKO.  
 
Table 7) Blocking solutions for immunofluorescence stainings on cryo sections 
Antibody Blocking solution (in PBS) 
GFP (chicken) 3% BSA, 5 % RS, 5 % NDS  
Laminin 10 % NGS  
Lrig1 2.5 % BSA, 0.25 % FSG, 0.1 % TritonX100 
Scd1 (goat) 10 % RS  
All used ingredients of the blocking solutions were purchased from Sigma, Germany.  
 
2.3.3.4) Immunofluorescence staining of cells 
 
Keratinocytes from K15CreER(T2)/R26EYFP mice were used for colony forming 
assays (2.6.5). To verify YFP expression after formation of colonies, 
immunofluorescence staining was performed. PFA-fixed cells (2.6.4) were 
permeabilised for 10 min with 0.5 TritonX100 in PBS (Sigma, Germany) and 
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blocked for 1h in 10 % NGS (Sigma, Germany). Antibody against GFP coupled 
to Alexa488 (1:500, Rockland) was incubated over night and washed off with 
PBS. Nuclei were stained with DAPI for 10 min at room temperature. After 
washing with PBS and distilled water, YFP expression was monitored using an 
Olympus IX80 fluorescence microscope equipped with an IX2-KCB camera.  
 
2.3.4) Immunohistochemistry (IHC) 
 
To visualise the basal layer of the epidermis, K14-IHC was performed on paraffin 
sections of mouse skin. Sections were deparaffinised and rehydrated. To 
unmask the antigens, sections were incubated in citrate buffer (Biogenex, USA) 
at 100°C for 20 min. To inhibit peroxidases within the tissue, the sections were 
treated for 20 min with 3% H2O2 in MeOH. After blocking with 10 % NGS for 1 h 
at room temperature, sections were incubated with primary antibody against K14 
(1:10000) over night at 4°C. After washing, secondary antibody coupled to 
horseradish peroxidase (HRP, DAKO Envision) was incubated for 30 min at 
room temperature followed by detection with AEC substrate (DAKO) for 2-3 min. 
To better visualise the histology of the skin sections, brief counter staining with 
diluted haematoxylin (1:4) was done. Sections were mounted with Kaisers 
glycerol gelatine. Analyses of the stainings were performed with a Leica 
DM4000B microscope (Leica Mikrosysteme GmbH, Wetzlar) and pictures were 
taken with a KY-F75U digital-camera (JVC Professional Europe Ltd., Frankfurt).  
 
2.3.5) Alkaline Phosphatase reaction (AP) 
 
Cells of the dermal papillae and the dermal condensate produce alkaline 
phosphatase (Handjiski et al., 1994). This enzyme dephosphorylates organic 
molecules. By adding a substrate for alkaline phosphatase on skin sections, the 
localisation of the DP or the dermal condensate can be visualised.  
Cryo sections (7-10 µm) of mouse tail skin were allowed to dry at room 
temperature and were fixed in ice cold acetone (-20°C) for 10 min. After washing 
in 1 x PBS, 20 µl of NBT/BCIP-solution (Roche, Germany) were mixed with 1 ml 
buffer reaction buffer (0.1 M Tris HCl, pH 9.5, 0.1 M NaCl). Alkaline phosphatase 
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dephosphorylates BCIP. The resulting product reacts with NBT and forms an 
insoluble blue dye. After 2-3 min of incubation at room temperature, enzyme 
activity could be detected as blue precipitation and the reaction was stopped by 
washing with dH2O. The sections were counter stained with Nuclear Fast Red 
(Sigma, Germany) and mounted with Kaiser’s glycerol gelatine (Merck, 
Germany). Images were taken using a Leica DM4000B microscope (Leica 
Mikrosysteme GmbH, Wetzlar) supplied with a KY-F75U digital-camera (JVC 
Professional Europe Ltd., Frankfurt). 
 
2.3.6) OilRedO staining 
 
OilRedO staining was used to visualise the lipids produced by mature sebocytes 
of the SG within the skin. OilRedO (Amresco, Ohio, US) was dissolved in 60 % 
2-propoanol by stirring for 1 h at RT to a concentration of 1 %. Before usage, the 
solution was filtrated. Epidermal whole mounts were equilibrated for 5 min in  
60 % 2-propanol and then incubated for 30 min up to 1 h in the OilRedO solution. 
After washing in PBS epidermal whole mounts were shortly counterstained with 
1:4 diluted haematoxylin (Merck, Germany) and mounted with Mowiol/DABKO. 
The stainings were visualised with a Leica DM4000B microscope (Leica 
Mikrosysteme GmbH, Wetzlar) supplied with a KY-F75U digital-camera (JVC 
Professional Europe Ltd., Frankfurt). 
 
2.4) Micro dissection 
 
For transcriptional analyses of different tumour cell populations, small pieces of 
tumour tissue were isolated using laser capture micro dissection. To prepare 
samples for laser micro dissection, 8 µm cryo sections of tumour tissue were cut 
with a cryostat (Leica, Germany) and mounted on special slides covered with a 
membrane facilitating micro dissection (ZEISS, Germany). The sections were 
kept in 70 % EtOH at -20°C until further usage. To visualise the structure of the 
tissue, a brief haematoxylin staining was performed. Sections were shortly 
washed in PBS, followed by distilled water and kept 10 sec in haematoxylin 
solution. Brief incubation in tap water was performed to develop the staining, 
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followed by incubation for 1 min in 70 %, 90 % and 100 % EtOH respectively. To 
avoid RNAse activity, all solutions were prepared with 0.1% DEPC treated water. 
Laser micro dissection was performed with a ZEISS Observer.Z1 microscope 
and a ZEISS PALM MicroBeam laser. Pictures were taken using a Hitachi HV 
D30 camera Isolated samples were captured in the cap of 0.5 ml micro tube 
(ZEISS, Germany). The tube cap was coated with 4 µl of mTRAP buffer (Active 
Motif, Belgium) supplied with 10 ng/µl tRNA (Roche, Germany). The collected 
tissue samples were directly frozen on dry ice and kept at -80°C until further 
usage.  
First, the accuracy of the method was tested (Fig. 10). SGs were isolated from 
cryo sections of mouse back skin. To assure that only SG tissue and no cells of 
the surrounding HF or dermis were cut out, presence of markers specific for the 
respective cell population was analysed by PCR (see 2.5.2). As shown in Figure 
10, all isolated SG-samples showed strong expression of the sebocyte 
differentiation marker Scd1. In contrast, the samples were negative for 
expression of the HF marker K19 and the dermal marker Vimentin. This 
demonstrates convincingly that laser micro dissection was precise enough to 
isolate distinct cell populations from skin.  
 
 
Fig. 10) Isolation of small tissue pieces and RT-PCR. A-F) Microsdissection of SG tissue from 
wt skin. Area of interest is marked with software (red line in B). Laser cuts along the marked line 
(C). Area of interest is catapulted away (wholes in D). Piece of tissue is collected in sample tube 
(red circle in E). Overview of section with area of interest (red circle in F). G) PCR-analysis of four 
different isolated SGs. IFE = Interfollicular epidermis, HF = hair follicle, SG = sebaceous gland, + 
= wt-skin, - = water control. Scale bars: 50 µm. 
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2.5) Molecular Biology 
2.5.1) Genotyping of experimental mice 
 
In order to identify the genotype of mice, tail biopsies were taken from 3 week old 
animals and proceeded as described below. 
 
2.5.1.1) Isolation of genomic DNA (gDNA) 
 
Tail biopsies were incubated in lysis buffer containing 0.2 M NaCl, 0.1 M Tris / 
HCl, pH 8.5, 5 μM EDTA, 0.2 % SDS and 100 μg/ml proteinase K (Sigma 
Aldrich, [39 U/mg]) for 3 h at 55°C and centrifuged for 30 min at 12000 rpm to 
pellet cellular debris. Supernatant was transferred to a new tube and 2 volumes 
of 2-propanol were added to precipitate gDNA. After centrifugation at 12000 rpm 
the gDNA pellet was resuspended in distilled water at 37°C over night and gDNA 
samples were kept at 4°C.  
 
2.5.2) Polymerase Chain Reaction (PCR) 
 
PCR was used to identify the genotype of mice. Generally, 500 ng gDNA were 
incubated with 10 pmol of primer pairs (see Table 8), 1U “ready to load enzyme 
mix” (Bio Budget, Germany) and 1x reaction buffer containing dNTPs (Bio 
Budget, Germany) in a total volume 25 µl. The PCR program used consisted of 
an initial denaturation step at 95°C for 5 min, followed by 30-35 cycles of 
denaturation for 30 sec at 95°C, primer annealing for 60 sec at the appropriate 
temperature and elongation of the PCR product for 45 sec at 72°C. After a final 
elongation step for 5 min at 72°C, the samples were kept at 4°C until gel 
electrophoresis was done to separate the DNA fragments.  
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Table 8) Genotyping primers 
Mouse strain Primer Oligonucleotide 5‘-3‘ 
R26EYFP (Srinivas et al., 
2001) 
YFP 1neu CCA AAG TCG CTC TGA GTT GTT ATC 
YFP 2 GCG AAG AGT TTG TCC TCA ACC 
YFP 3wt GGA GCG GGA GAA ATG GAT ATG 
K15CreER(G)T2  
(Petersson et al., 2011) 
K15 for AGG TGT GCG GGC AGC TGT GTT TGT 
K15 rev  GGA CAT CTT CCC ATT CTA AAC AAC ACC CTG 
K14∆NLef1 
(Niemann et al., 2002) 
dNLef_for_neu TGT CCC TTG TAT CAC CAT GGA CC 
dNLef_rev CCA AAG ATG ACT TGA TGT CGG CT 
K14L61Rac1 
(Tscharntke, 2006) 
SF3 TTG GTT GTG TAA CTG ATC AGT AGG C
SF5 TGG AGA GCT AGC AGG AAA CTA GG 
All primers were purchased from MWG, Germany 
 
Moreover, PCR was used to verify gene expression in cDNA samples from 
isolated tissue (2.5.5 and 2.5.6). In general, 1 µl of cDNA was used as template 
and incubated with the same reaction mix as described above. Primers used for 
detections of cDNA are listed in Table 9. The PCR was carried out applying the 
program described above.  
All PCR reactions were done in TGradient Thermocycler or Personal 
Thermocycler (Biometra). 
 
Table 9) PCR primers for cDNA samples (conventional and real time PCR) 
Gene Primer Oligonucleotide 5‘-3‘ 
GAPDH 
GAPDH for AAC TTT GGC ATT GTG GAA GG 
GAPDH rev ACA CAT TGG GGG TAG GAA CA 
K19 
K19 for TGC TGG ATG AGC TGA CTC TG 
K19 rev AAT CCA CCT CCA CAC TGA CC 
Scd1 
Scd1 for ACA ACT ACC ACA CCT TCC CCT TC 
Scd1 rev AGC CCA AAG CTC AGC TAC TCT TGT GAC 
Vimentin 
Vimentin for CAG CTC ACC AAC GAC AAG G 
Vimentin rev TTC CAC TTT CCG TTC AAG GT 
Elovl3 
Elovl3 for CTG TTG CTC ATC GTT GTT GG 
Elovl3 rev GCT TGA GGC CCA CTG TAA AC 
Elovl4 
Elovl4 for GGGATCATACAACGCAGGATA 
Elovl4 rev CCA CCA CAG AGT GAA CAT GG 
18S rRNA 
18S for CCT GCC CTT TGT ACAC 
18S rev CGA TCC GAG GGC CTC AC 
All primers were purchased from MWG, Germany 
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2.5.3) Agarose gel electrophoresis 
 
To determine the size of PCR amplified DNA fragments, PCR samples were 
separated on 2 % Agarose (w/v) gels in 1 x TAE electrophoresis buffer at 100 V. 
The correct size of the PCR products was identified with the help of a DNA low 
range marker (Fermentas, Germany).  
 
2.5.4) Quantitative real-time-PCR  
 
Harvested tissue was snap frozen in Trizol (Ambion, Life Technologies, 
Germany). To isolate RNA, samples were thawed at RT and tissue in Trizol was 
shred into small pieces using a tissue disintegrator (Janke & Kunkel, Germany). 
To purify RNA, the general protocol provided with the Trizol reagent (Ambion, 
Life Technologies, Germany) was applied according to the manufacturer’s 
indications. Isolated RNA was dissolved in RNAse free water and kept at -80°C. 
To synthesize cDNA, the QuantiTect Reverse Transcriptase Kit (Qiagen, 
Germany) was used according to the manufacturer’s protocol. CDNA samples 
were kept at 4°C.  
To evaluate the expression levels of various genes, qRTPCR was performed 
using RT2 RT SYBR Green qPCR Master Mix (SuperArray Bioscience 
Cooperation, USA) or TaqMan gene expression assays (Applied Biosystems). 
For qRTPCR with SYBR green, 5 pmol primer pair was mixed with SYBR green 
master mix and 1 µl template DNA (cDNA libraries were diluted 1:10) in a total 
volume of 10 µl (SuperARRAY Biosciences Cooperation, USA). TaqMan gene 
expression assays were carried out in a total volume of 10 µl per well according 
to the manufacturer’s instructions (Applied Biosystems).  
The real time PCRs were done in 96 well plates and run in a StepOnePlus real 
time PCR system (Applied Biosystems). The used primers and probes are listed 
in Table 9 and 10.  
The expression levels were calculated relative to expression of 18S rRNA (SYBR 
green) or GAPDH (TaqMan) using the delta ct method. 
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Table 10) TaqMan probes 
Gene TaqMan probe (assay ID, Applied Biosystems)
Dhcr24 Mm00519071_m1 
Nupr1 Mm00498104_m1 
Scd1 Mm00772290_m1 
GAPDH Mm99999915_g1 
 
2.5.5) mRNA isolation and cDNA synthesis 
 
To test whether micro dissection was precise (2.4) a “quick protocol” combining 
mRNA isolation and cDNA synthesis was used. Tissue samples (in mTRAP lysis 
buffer), isolated by micro dissection, were allowed to thaw on ice. To collect 
tissue and mTRAP buffer at the bottom of the tube, samples were shortly 
centrifuged. 10 mM of dNTPs and 50 ng of Random Hexamers (both 
SuperScript® III First-Strand Synthesis Kit, Invitrogen, Germany) were added. To 
lyse the isolated cells, samples were put for 5 min at 65°C on a thermo shaker 
(Eppendorf, Germany) and directly transferred on ice. Next, each sample was 
supplied with 1 µl of 10 x RT buffer, 0.5 µl “RNaseOUT”, 0.5 µl 10 mM DTT and 
1 µl Superscript III enzyme (all components SuperScript® III First-Strand 
Synthesis Kit, Invitrogen, Germany). To allow annealing of the random hexamers 
to the mRNA, samples were incubated for 5 min at 25°C in a thermocycler 
(Biometra). For reverse transcription of the mRNA into cDNA, samples were 
incubated at 50°C for 60 min. Finally, the reaction was stopped by keeping the 
samples for 15 min at 70°C. Samples were stored at 4°C until further usage.  
 
2.5.6) cDNA-library-generation 
 
To analyse and compare gene expression in different cell populations of the skin 
or in skin tumours, cDNA libraries were generated as described by Hartmann 
and Klein (Fig. 11). In principle, this method allows analysing the transcription 
profile of one single cell and can be applied for small pieces of tissue as well. 
RNA is isolated and reversely transcribed into cDNA. Amplification of the cDNA 
of the whole transcriptome of the cell is performed to yield enough cDNA for 
micro array analysis (Hartmann and Klein, 2006). 
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In this study, the method was used to compare transcription profiles of different 
cell populations within skin tumours. Therefore, small tissue pieces (10-100 cells) 
were collected in mTRAP lysis buffer (2.4). 1 µg of Protease (Active Motif, 
Belgium) and biotinylated oligo-dT peptide nucleic acids (PNAs, Active Motif, 
Belgium) were added to the sample (Fig. 11 A). Proteolytical digestion of the 
cells was carried out at 45°C for 10 min. An incubation step at 70°C for 1 min 
and at 22°C for 15 min followed, allowing the PNAs to bind to the released 
mRNA (Fig. 11 B). Streptavidin conjugated magnetic beads (4 µl, Active Motif, 
Belgium) were added and the tubes were kept for 45 min at room temperature on 
a rotator (Stuart) (Fig. 11 C). As the affinity between streptavidin and biotin is 
very high, biotinylated PNAs attached to the mRNA bound to the magnetic 
beads. To wash off lysis buffer, cellular debris and gDNA, 10 µl of wash buffer 1 
(Table 12) were added to the tubes. To separate the gDNA and the cellular 
debris from the mRNA, the tubes were placed on a magnetic rack (Invitrogen, 
Germany). Magnetic streptavidin-conjugated beads bound to mRNA are pelleted, 
whereas gDNA and cellular debris remain dissolved in the supernatant. The 
supernatant was transferred to a fresh tube and 20 µl of wash buffer 2 (Table 12) 
were added to the beads. After having placed the tubes on the magnetic rack, 
the supernatant was transferred to the fresh tube and 20 µl of wash buffer 1 were 
added. Tubes were placed on magnetic rack and supernatant was removed for 
the third time. Next, 20 µl of reaction mix for reverse transcription were mixed 
with the beads (Fig. 11 D). Primers were allowed to anneal for 15 min at room 
temperature. Reverse transcription was carried out at 44°C for 45 min. Then, 20 
µl of tail wash buffer (Table 12) were added and the tubes were placed on the 
magnetic rack. Supernatant was discarded and 10 µl of tailing buffer (Table 12) 
were added. To release the mRNA-cDNA hybrids from the magnetic beads, 
denaturation was carried out at 94°C for 4 min (Fig. 11 E). Terminal 
deoxynucleotide transferase (10 U, Amersham, Freiburg, Germany), catalysing 
the addition of a G-tail to the cDNA, was added (Fig. 11 F). The samples were 
first incubated for 60 min at 37°C for the tailing reaction. Afterwards, the enzyme 
was inactivated by incubation at 70°C for 5 min. To amplify the synthesised 
cDNAs, PCR was performed. 5.5 µl of the following mix were added to each 
sample: 350 mM dNTPs, 1.2 µM CP2-primer (Table 11) and 5 U Pol Mix (DNA 
Polymerase, Expand Long Template Kit, Roche, Germany) (Fig. 11 G). The PCR 
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programme comprised 20 cycles of 15 s denaturation at 94°C, 30 s of primer 
annealing at 65°C and 2 min of primer extension at 68°C followed by 20 cycles 
with a 10 s elongation of the extension time and a final elongation step at 68°C 
for 7 min. 
After PCR-amplification, the cDNA libraries were stored at -20°C. To assure that 
mRNA was successfully transcribed into cDNA, PCR for 18S or GAPDH was 
performed (2.5.1.2). If positive results were obtained by PCR, gene expression 
profiles of cDNA libraries were determined by oligo nucleotide arrays (2.5.7).  
 
Table 11) Primers used for cDNA library generation 
Primer Oligonucleotide sequence
CFL15CN8 C15GTCTAGAN8 
CFL15CT24 C15GTCTAGAT24VN 
CP2-primer TCAGAATTCATGC15 
N = any base, V = A, C or G; Primers were purchased from Metabion, Germany.  
 
Table 12) Solutions for library generation 
solution components 
Wash buffer 1  
50 mM Tric-HCl, pH 8.3 
75 mM KCl 
3 mM MgCl2 
10 mM DTT 
0,25 % Igepal 
Wash buffer 2 
50 mM Tris-HCl, pH 8.3 
75 mM KCl 
3 mM MgCl2 
10 mM DTT 
0.5% Tween-20 
Reverse transcription  
reaction mix 
0.5 mM dNTPs 
200 U SuperScript II 
30 µM CFL15CN8 primer 
15 µM CFL15CT24 
0,25 % Igepal 
10 mM DTT 
SuperScript-buffer (Invitrogen)
Tail wash buffer  
50 mM KH2PO4, pH 7 
1 mM DTT 
0,25 % Igepal 
Tailing buffer 
10 mM KH2PO4, pH 7 
4 mM MgCl2 
0.1 mM DTT 
200 µM dGTP 
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Fig. 11) Generation of cDNA libraries. Scheme depicting the main steps during synthesis of 
cDNA libraries. Modified from Hartmann and Klein, 2006.  
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2.5.7) Oligonucleotid array analysis 
 
In order to analyse the gene expression profile of the cDNA libraries, 
oligonucleotide array analysis was performed (Hartmann and Klein, 2006). 
Therefore, the cDNA libraries were labelled with digoxygenin-conjugated 
nucleotides. The reaction was performed in a PCR cycler (MJ research) in the 
presence of 3 % formamide, 2.4 µM CP2-BGL-primer (Table 11), dNTPs (0.35 
mM dATP and dGTP, 0.3 mM dTTP and dCTP), 0.05 mM digoxygenin-labelled 
nucleotides (Roche and Perkin Elmer), TAQ-polymerase and the appropriate 
reaction buffer (Roche, Germany). A reference sample containing cDNA from 
different mouse tissues was labelled with biotin-conjugated nucleotides. The 
labelled cDNA libraries were purified using QIAGEN purification columns 
(QIAGEN Germany).  
Murine large-scale oligonucleotide micro arrays containing 17000 
oligunucleotides of 70 nt length (Operon, Netherlands) were prehybridised for 45 
min at 42°C in prehybridisation buffer (Table 13). Hybridisation of the labelled 
cDNA libraries onto the micro array slide was carried out in an Arraybooster 
hybstation (Implen, Munich) at 42°C over night. The micro arrays were washed 
twice in wash buffer 1, followed by wash buffer 2 and wash buffer 3 (Table 13) 
for 10 min at 50°C. To detect differences in gene expression between the sample 
and the reference, the labelled cDNA fragments hybridised onto the array were 
stained with antibodies against digoxygenin and biotin (anti-Dig-Cy5 and 
streptavidin-Cy3, Jackson laboratories). After washing with wash buffer 4 (Table 
13), the micro array slides were scanned in a Genepix 4000A scanner (Axon 
Instruments, Union City).  
 
Table 13) Solutions for Oligonucleotide array hybridisation 
solution components 
Prehybridisation buffer 
5 x SSC 
0.1 % SDS 
0.1 % BSA 
Wash buffer 1 1 x SSC 0.1 % SDS 
Wash buffer 2 0.5 x SSC 0.1 % SDS 
Wash buffer 3 0.1 x SSC 
Wash buffer 4 4 x SSC 0.2 % Tween-20 
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Micro array data were analysed using GeneSpring and normalized by Lowess in 
the group of Christoph Klein in Regensburg. Gene expression profiles of basal 
cells from K14ΔNLef1/L61Rac1 adenoma were compared to sebocytes from 
K14ΔNLef1/L61Rac1 adenoma and undifferentiated cells from 
K14ΔNLef1/L61Rac1 carcinoma. Also, profiles of sebocytes from 
K14ΔNLef1/L61Rac1 adenoma were compared to undifferentiated cells isolated 
from K14ΔNLef1/L61Rac1 carcinoma. 
 
2.6) Cell biology  
2.6.1) Isolation of primary keratinocytes 
 
Primary keratinocytes were isolated from mice at P 1-3. Mice were sacrificed, 
and disinfected with Betaisodona (Mundipharma, Germany) and 70 % EtOH. 
Back and tail skin was harvested and floated (dermal side down) on 0.5 % (v/v) 
Thermolysin (Sigma, Germany) diluted in DMEM-Hams/F12-medium (Biochrom, 
Germany) (without additives) for 30 min up to 1 h. The epidermis was isolated 
from the dermis using forceps, minced in DMEM-Hams/F12 medium (without 
additives) and incubated for 15 min on a rotator (ELMI RM-2L) in DMEM-
Hams/F12 medium. Isolated keratinocytes were filtered (70 µm, BD, Germany). 
In order to obtain a defined input of cells for FACS analyses cell number was 
determined with a CASY cell counter. For FACS analyses, cells were stained as 
described below.  
 
2.6.2) Cultivation of J2-3T3 fibroblasts and primary keratinocytes  
 
J2-3T3-fibroblasts were cultured in DMEM-medium (GIBCO, Germany) 
supplemented with 10 % FCS (PAA, Germany), penicillin (100 U/ml) and 
streptomycin (100 μg/ml) (Biochrom, Germany) at 37°C and 5 % CO2. For 
keratinocyte co culture, fibroblasts were treated for 2 h with 4 µg/ml Mitomycin C 
(Sigma, Germany) to inhibit proliferation of the fibroblasts.  
FAC-sorted (see 2.6.3) primary keratinocytes were co cultured with Mitomycin C 
pre-treated J2-3T3-fibroblasts. Co culture was necessary as fibroblasts produce 
matrix components required for keratinocyte attachment and growth. Cell culture 
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was performed on collagen-coated culture dishes (Beckton Dickinson, UK) in 
DMEM-Hams/F12 medium (Biochrom, Germany) supplemented with penicillin 
(100 IU/ml), streptomycin (100 μg/ml) (Biochrom, Germany), adenine (1.8 x 10–4 
M) (Sigma, Germany), gluthamine (2 mM) (Biochrom, Germany), hydrocortisone 
(0.5 μg/ml), epidermal growth factor (Shubbar et al.) (10 ng/ml), cholera 
enterotoxin (10–5 M), insulin (5 μg/ml) (Sigma, Germany) and 10 % fetal calf 
serum (FCS Gold) (PAA, Germany). To avoid differentiation of keratinocytes, 
stimulated by Ca2+, FCS was treated with Chelex-100 resin (BioRad, Germany) 
over night at room temperature, pH 7. The treated FCS was sterile filtered before 
being added to the medium.  
Cells were kept at 32°C in an atmosphere of 5 % CO2 in a humidified incubator 
(Carroll et al., 1995; Morris et al., 1987; Rheinwald, 1989; Rheinwald and Green, 
1975).  
 
2.6.3) Fluorescence activated cell sorting  
 
To purify YFP positive cells from isolated primary keratinocytes, Fluorescence 
activated cell sorting (FACS) was performed. For characterisation of YFP 
positive cell populations within the skin of newborn K15CreER(T2)/R26EYFP-
mice, primary keratinocytes were isolated as described in 2.6.1. In these mice, 
Tamoxifen-inducible Cre recombinase is expressed in K15-expressing cells. The 
mice had been treated with Tamoxifen intra uterally during embryogenesis to 
induce YFP expression in cells expressing the Keratin15 promoter. In newborn 
mice, K15 expression is detected in cells of the IFE (Liu et al., 2003; Nöbel, 
2009).  
To purify YFP positive cells from isolated primary keratinocytes, a defined 
number of primary keratinocytes was subjected to FACS-analysis.  
Isolated primary keratinocytes were co stained with an antibody against Itgα6 
(PE-coupled, BD, Germany) for 45 min at 4°C to mark basal epithelial cells 
(Nowak and Fuchs, 2009; Watt, 2002). Cell viability was detected by staining 
with PI (Sigma, Germany). FAC-sorting of the cells was done with a FACS-Aria 
III (Beckton-Dickinson). YFP positive/Itgα6high and YFPnegative/Itgα6high cells 
were sorted to compare clonogenic potential of YFP positive versus YFP 
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negative basal epidermal cells. Cells were collected in tubes with DMEM-
Hams/F12 medium and directly plated out on collagen coated dishes (Beckton 
Dickinson, UK) with growth inhibited fibroblasts (see 2.6.2).  
 
2.6.4) Colony forming assay 
 
Colony forming assays were performed to evaluate the clonogenic and growth 
potential of FAC sorted keratinocytes isolated from K15CreER(T2)/REYFP mice.  
YFP positive and YFP negative epidermal cells (3000, 6000 and 10000) were 
plated in triplicates on collagen coated 6-well plates with growth arrested 
fibroblasts (see 2.6.2). Keratinocytes were allowed to grow at 32°C and 5 % CO2 
in DMEM-Hams/F12 medium for three weeks to form colonies. Fibroblasts were 
washed off with 0.02% EDTA in PBS and the keratinocytes were fixed for 10 min 
with 4 % PFA. To verify YFP expression in the cells, immunofluorescence 
staining was performed (see 2.3.3.4). For evaluating the colony forming 
efficiency, colonies were stained with 0.05 % crystal violet (Sigma, Germany) for 
1h and washed with PBS for 15 min. Colonies were classified according to their 
size. Large colonies (>2 mm2) are derived from holoclones having a high 
reproductive capacity. Colonies smaller than 1 mm2 originate from a paraclone 
with short replicative lifespan. Meroclones form colonies of 1-2 mm2 size with 
intermediate characteristics (Barrandon and Green, 1987). Area of the colonies 
was measured with ImageJ (version 1.41 b, National Institutes of Health, USA). 
The clonogenic potential was calculated for YFP positive and YFP negative cells 
by dividing the number of colonies by the number of plated cells and multiplying 
by 100%.  
 
                                                                                                              Results 
43 
3) Results 
3.1) Analysis of SG and HF morphogenesis in mouse tail skin 
 
HF morphogenesis in mouse back skin has been extensively studied over the 
past decades. Progress has been made understanding the underlying cellular 
and molecular mechanisms of HF formation (Fuchs, 2007; Millar, 2002; Paus et 
al., 1999; Schmidt-Ullrich and Paus, 2005; Schneider et al., 2009).  
In contrast to back skin HF development, less is known about the formation of 
tail skin HFs. Nevertheless, mouse tail skin is often used as a tool to study 
cellular and molecular processes within HFs (Braun et al., 2003; Janich et al., 
2011; Jensen et al., 2009; Jensen et al., 2008b; Petersson et al., 2011).  
It has been described that tail skin HFs are arranged in triplets (Schweizer and 
Marks, 1977). However, it remains unknown how tail follicle morphogenesis is 
regulated, if the required signals differ from back skin and how HF triplets are 
formed. Here, we investigate the processes of HF triplet formation during early 
morphogenesis in more detail. 
 
3.1.1) HFs in mouse tail skin develop in two waves  
 
To investigate the timing of the formation of HF triplets during morphogenesis, 
tail skin sections and epidermal whole mounts were analysed from P0 to P8 (Fig. 
12). Development of HFs was evaluated according to defined morphological 
stages (Paus et al., 1999). 
Formation of HFs is initiated by a molecular crosstalk of the epidermis with the 
underlying mesenchyme. First, mesenchymal signals define where HFs will be 
formed. Subsequently, epidermal signals lead to the formation of epidermal 
thickenings (placodes) (Fuchs, 2007). A signal from the placode to the 
mesenchyme induces the formation of a dermal condensate beneath the 
placode. The epithelial placode stretches towards the dermal condensate 
forming the hair germ (HG). Further elongation of the HG leads to enclosure of 
the dermal condensate forming the dermal papillae (DP) (Botchkarev and Paus, 
2003; Duverger and Morasso, 2009; Paus et al., 1999). 
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In tail skin sections, HGs (stage 2) were seen regularly distributed over the skin 
sample and grew deeper into the dermis with further development (Fig. 12 A, B, 
K and L). Once HFs had reached stage 3 or 4 of HF morphogenesis (Paus et al., 
1999), new placodes formed adjacent (left and right) to the first central HF (Fig. 
12 C, H, Q and V).  
Alkaline phosphatase (AP) staining was used to detect dermal condensates and 
DP (Handjiski et al., 1994). Dermal condensates underneath the placode and HG 
of the central follicle could be detected at stage 2, 3 and 4 of HF morphogenesis 
(Fig. 12 F-H). At stage 4 of HF development, the bulb of the central follicle had 
enclosed the dermal condensate thereby forming the DP. New dermal 
condensates could be detected below the placodes of the left and right side 
follicle (Fig. 12 H, I, J).  
Taken together, analysis of tail HF development between P0 and P8 
demonstrates that HFs of triplets are generated in two waves. First, the central 
follicle was formed and the two side follicles developed with a delay of 2-3 stages 
of HF morphogenesis (Fig. 12).  
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Fig. 12) HF morphogenesis in tail skin proceeds in two distinct waves. A-E) Hematoxylin 
and Eosin (H&E) stained skin sections of early postnatal development. Note emergence of 
sebocytes (arrow in D and in inset). F-J) Alkaline phosphatase (AP) staining to detect the dermal 
condensate (arrowhead) and dermal papillae (DP) (arrow). Note arising dermal condensates 
(arrowheads in F-I). K-O) K14-immunohistochemistry to mark the basal layer of the IFE. P-T) 
Epidermal whole-mounts stained with Hematoxylin and OilRedO. Note appearance of outer 
follicles (arrowheads in Q) and first visible sebocytes (arrowheads in S). U-Y) Scheme depicting 
the different stages of tail HF morphogenesis (DP-cells in blue, sebocytes in red). Scale bars: 50 
µm. 
 
3.1.2) HF morphogenesis in tail skin is delayed compared to back 
skin 
 
Next, we compared the time point of HF initiation in back and tail skin.  
It is known, that HF morphogenesis in mouse back skin starts with the formation 
of primary guard hairs at E14.5 (Schmidt-Ullrich and Paus, 2005). We have 
compared back and tail skin samples of the same animals at different time points 
during morphogenesis (n=3 embryos per time point). At E15.5 when placodes 
have already formed in back skin (Fig. 13, upper row); tail skin does not show 
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epidermal thickenings or placodes (Fig. 13, lower row). Epidermal thickenings 
could first be detected at E16.5 in mouse tail skin (Fig. 13, lower row). This 
demonstrates that HF formation in tail skin was initiated with a delay of 
approximately one day compared to back skin.  
 
 
Fig. 13) Timeline of HF morphogenesis in mouse back and tail skin. Comparison of 
Hematoxylin and Eosin stained sections of mouse back and tail skin (E15.5 - E17.5). Note that 
HFs develop later in tail skin. P = placode. Scale bar: 50 µm. 
 
3.1.3) Different HF patterning in back and tail skin 
 
Another striking difference between tail and back skin samples is the spatial 
organisation of HFs within the skin. 
In back skin, different types of HFs are known. Guard HFs make up 1-3 % of the 
coat HFs. They produce long tylotrich hair that has also sensory function. 
Awl/Auchene hair makes up 30 % of the mouse coat. They are shorter than 
guard hairs. A third type of HFs produces zig zag hair, also known as undercoat 
hair. The different types of HFs develop in three distinct waves starting with the 
development of guard hairs at E14.5. In the second wave, awl/auchene HFs are 
formed around E16.5. The third wave of HF formation occurs at E18.5 forming 
the zizag HFs (Duverger and Morasso, 2009; Schmidt-Ullrich and Paus, 2005). 
Mouse back skin HFs are arranged in a specific pattern. Guard HFs are first 
interspersed by awl/auchene HFs and finally, zigzag HFs fill the remaining 
spaces (Duverger and Morasso, 2009) (Fig. 14 A, C). In mouse tail skin, HFs 
develop in two waves (Fig. 12 P-Y). So far it is unknown if two types of HFs 
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distinguished by differences in structure and size are formed during these two 
waves. Furthermore, tail skin HFs are arranged in a distinct pattern different from 
the one observed in back skin (Fig. 14 B, D). Groups of three HF constitute a 
triplet. The triplets are arranged in rows from the anterior to the posterior end of 
the tail. Interestingly, we could detect triplets of HFs at different stages of 
development within one row of HF triplets. At P1.5, HFs on the dorsal side of the 
tail had reached stage 6 of morphogenesis (Fig. 14 B). In contrast, at the ventral 
side, HF morphogenesis had only proceeded to stage 4 (Fig. 14 B).  
Taken together, these data show that tail skin HFs are arranged in a different 
pattern than HFs in back skin. Moreover, development of HFs in tail skin follows 
a gradient from the dorsal to the ventral side of the tail.  
 
Fig. 14) Comparison of HF patterning in back and tail skin. A,B) Hematoxylin and OilRedO 
stained epidermal whole mounts of back (A) and tail skin (B) at P 1.5. Note different types of HFs 
in back skin in A (1= guard hairs, first wave; 2= awl/auchene hairs, second wave; 3= zigzag hairs, 
third wave). In tail skin two types of HFs are formed (1=central HF, first wave; 2=side follicles, 
second wave). Arrows point to SGs. C, D) Scheme depicting patterning of HF in back (C, 
modified from Duverger and Morasso , 2009) and tail (D) skin. Note different waves of HF 
formation (first wave: dark grey; second wave: light grey; third wave; white). Scale bar 50 µm.  
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3.1.4) Two SGs emerge from one cluster of sebocytes 
 
One crucial event during HF morphogenesis is the formation of the SG. The SG 
is a holocrine gland attached to the HF. It provides lipids (sebum) thereby 
contributing to maintaining an intact epidermal barrier (Niemann, 2009; 
Schneider and Paus, 2009). Until now, the development of the SG is not well 
characterised. To understand cellular processes during SG development, we 
have analysed SG formation in more detail.  
The SG is formed at stage 5 of HF morphogenesis at the upper part of mouse 
back skin pelage HFs (Paus et al., 1999). Mature sebocytes were identified by 
staining with the lipid dye OilRedO. In tail skin, first sebocytes were detected at 
the upper part of HFs that had reached stage 5 of HF morphogenesis (Fig. 12 S, 
15 A). As the HF developed further, the number of sebocytes increases forming 
a cluster (Fig. 15 B, C). Once the HF had reached stage 7 of development, the 
agglomeration of sebocytes splits up, thereby generating two small clusters of 
cells (Fig. 15 C). Each of these clusters progresses into one glandular structure 
with a sebaceous duct (Fig. 15 C, D, E). Surprisingly, the two SGs attached to 
adult HFs are formed from one single group of cells.  
To study the process of SG formation in more detail, we have analysed the 
expression of Scd1 (stearoyl CoA desaturase 1) and adipophilin. Scd1 is an 
enzyme of the fatty acid metabolism, converting saturated into monounsaturated 
fatty acids (Enoch et al., 1976). It has been shown that Scd1 is essential for 
proper SG maintenance and skin barrier function (Binczek et al., 2007; Miyazaki 
et al., 2001). Adipophilin is expressed by lipid producing cells and localises to the 
lipid droplets in the cytoplasm (Heid et al., 1998). We detected Scd1 expression 
at stage 5 of HF morphogenesis when first sebocytes are formed (Fig. 15 F). At 
this stage, sebocytes could also be visualised by OilRedO staining (Fig. 15 A). 
Remarkably, adipophilin expression was found slightly delayed to Scd1 (Fig. 15 
F, G) and not all cells of the growing SG were positive for both markers (Fig. 15 
G-I). This indicates that adipophilin marks a subpopulation of sebocytes. Another 
possibility could be that adipophilin is expressed by more mature sebocytes than 
Scd1.  
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Taken together, these data show that two SGs of mouse tail skin HFs are formed 
from one single cluster of sebocytes.  
 
Fig. 15) Development of the SG in mouse tail skin. A-E) Hematoxylin and OilRedO stained 
epidermal whole mounts at stage 5, 6, 7, 8 of HF morphogenesis and adult age. Note 
appearance of sebaceous ducts at stage 8 (arrows in D). F-I) Adipophilin (Adipo, green), Scd1 
(red) and K14 (blue) stained epidermal whole mounts visualizing the developing SG at stage 5, 6, 
7 and 8. Note that two SGs develop from one cluster of cells. Scale bar: 25 µm. 
 
3.1.5) Proliferation during HF morphogenesis is not confined to a 
distinct region of the HF 
 
During HF morphogenesis, massive proliferation is required to provide cells for 
the growing HF. To analyse where proliferation takes place and if it is confined to 
particular regions of the HF during morphogenesis, a short pulse (1 h) BrdU-
incorporation assay was performed (Fig. 16). Proliferation analysis revealed that 
dividing cells are not accumulated in a particular area of the HF (Fig. 16 A, B, C, 
D). BrdU positive cells were scattered all along the HF between stage 2 and 
stage 6 of HF morphogenesis indicating that all cell compartments of the HF 
expand to a similar extent.  
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Fig. 16) Localisation of proliferating cells during HF morphogenesis. A-B) Epidermal whole 
mounts stained with antibodies against BrdU (red), Scd1 (green) and keratin14 (K14, blue) at 
stage 2 (A), stage 3 (B), stage 5 (C) and stage 6 (D) of HF morphogenesis. Scale bar : 50 µm 
 
3.1.6) Spatio-temporal analysis of stem and progenitor cell 
populations during HF morphogenesis  
 
Various stem cell populations contributing to regeneration of the HF and SG 
have been identified (Blanpain and Fuchs, 2009; Jaks et al., 2010; Petersson et 
al., 2011). In particular, the bulge region, the junctional zone and the isthmus of 
the adult HF have been shown to contain stem and progenitor cells able to 
reconstitute HFs and SGs (Jensen et al., 2009; Jensen et al., 2008b; Nijhof et 
al., 2006). To analyse when stem cell compartments are established, expression 
of molecules marking the above mentioned cell compartments, was analysed 
during early postnatal tail skin development.  
Sox9 has been shown to be a robust marker for HF stem cells residing in the 
bulge region (Vidal et al., 2005). Furthermore, it has been shown that the stem 
cell population expressing Sox9 is already established in placodes of pelage HF 
from E15.5 onwards (Nowak et al., 2008). To investigate if the Sox9 positive cell 
population is also established during early tail HF morphogenesis, we have 
performed immunofluorescence stainings for Sox9 together with P-Cadherin 
(PCad). PCad marks the lower portion of the developing HF (Nowak et al., 
2008). Our analyses showed that Sox9 also marks a distinct cell population 
above the PCad positive compartment at stage 2 of HF morphogenesis in tail 
skin (Fig. 17 A). As the HF elongated, the Sox9 expressing compartment 
expanded further (Fig. 17 B, C). At stage 5 of HF morphogenesis, Scd1 
expressing sebocytes were detected (Fig. 17 D, E). Of note, these arose above 
the Sox9 expressing zone which localised to the presumable future bulge region 
at this stage of HF morphogenesis.  
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Recently, Lrig1 has been shown to be expressed by stem and progenitor cells of 
the junctional zone of the HF able to give rise to cells of the SG and IFE in adult 
skin (Jensen et al., 2009). Cells in the isthmus region of the HF express the 
MTS24-antigen Plet1 (MTS24/Plet1). These cells showed a high clonogenic 
potential in vitro (Nijhof et al., 2006). Moreover, cells of the upper isthmus were 
able to give rise to HF, SG and IFE in reconstitution assay (Jensen et al., 
2008a). To investigate if Lrig1 or MTS24/Plet1 positive cells potentially 
participate in morphogenesis of the SG, expression of these markers was 
analysed during early HF development. Lrig1 expression was already detected at 
stage 2 of HF morphogenesis (Fig. 17 F). Similar to the Sox9 positive 
keratinocytes, the cluster of Lrig1 expressing cells expanded as the HF 
elongated, but remained at the upper part of the HF (Fig. 17 G, H). Interestingly, 
Scd1 positive cells could be detected in the Lrig1 positive compartment 
indicating that sebocytes were formed surrounded by Lrig1 positive cells (Fig. 17 
I, J). In contrast, MTS24/Plet1 expression was not detected before stage 6-7 of 
HF morphogenesis (Fig. 17 K-M), once first sebocytes had been formed at the 
upper part of the HF (Fig. 17 M).  
Taken together, these data show that Sox9 and Lrig1 are expressed prior SG 
formation and could potentially play a role in its formation. MTS24/Plet1 positive 
cells however are unlikely to contribute to SG formation as expression of this 
marker could only be detected at stage 7 when first sebocytes were already 
visible.  
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Fig. 17) Expression of stem and progenitor markers during HF morphogenesis. A-E) 
Immunofluorescence staining of Sox9 (green), Scd1 (blue) and P-Cadherin (PCad, red) of 
epidermal whole mounts during HF development. Note appearance of first sebocytes at stage 5 
of HF morphogenesis (arrowheads in D and E). F-J) Expression analysis of Lrig1 (green), Scd1 
(blue) and Keratin 14 (K14, red) shows that sebocytes (arrowheads in I and J) arise within the 
Lrig1 positive zone of the developing HF. K-M) Staining for MTS24/Plet1 (red) Scd1 (green) and 
K14 (blue) reveals that sebocytes (arrowheads in L) arise before progenitor marker MTS24/Plet1 
(arrows in M) is detected. Scale bars: 100 µm 
 
3.1.7) Dynamic expression of stem cell markers Lrig1 and Sox9 
during HF and SG morphogenesis 
 
Analysis of Lrig1 and Sox9 expression demonstrated that both markers are 
expressed from early HF morphogenesis onwards. Immunofluorescence 
stainings revealed expression of Lrig1 and Sox9 in the same region of the 
developing HF (Fig. 17 A-E and F-J). To investigate if both markers are 
expressed by the same cells, co immunofluorescence stainings were performed 
(Fig. 18). Lrig1 and Sox9 are indeed co expressed by cells of the HF at stage 3 
and 4 (Fig. 18 A, B, E). Interestingly, at stage 5 of HF morphogenesis when 
sebocytes first arise (Fig. 17 D, I, L), either marker is expressed by distinct 
compartments within the HF and this pattern remains throughout further 
development (Fig. 18 C, D, F). In particular, Lrig1 expressing cells localize to the 
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upper part of the HF, close to the IFE, where the SG will be formed. In contrast, 
Sox9 expressing cells localise further down the HF at the future bulge region. 
These data suggest a dynamic expression of Lrig1 and Sox9 during HF 
morphogenesis. Co expression of both markers at earlier stages of HF 
morphogenesis suggests that both stem cell compartments share characteristics 
of simple progenitors during development. By mechanisms that are not known so 
far, the cell populations separate during HF morphogenesis. Localisation of Lrig1 
expression at the upper part of the HF once the SG starts to form indicates that 
Lrig1 positive stem cells are likely to play a role in formation of the SG.  
 
Fig. 18) Dynamic expression of progenitor markers Lrig1 and Sox9 during HF 
morphogenesis. A-F) Epidermal whole mounts analysed for expression of stem cell marker 
Sox9 (green) and Lrig1 (red). Co expressing cells are marked with white arrows in E and F. Red 
arrowheads (A-D) mark the Lrig1 stem cell compartment, green arrowheads (A-D) and white 
arrowheads (E, F) point to Sox9 expressing cells. A-D) Z-projections of epidermal whole mounts, 
E, F) sections through epidermal whole mounts. Scale bars: A-D) 100µm, E,F) 20µm.  
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3.2) Cellular mechanisms of SG morphogenesis 
3.2.1) Sebocytes emerge adjacent to Lrig1 expressing cells 
 
Our initial results suggested that Lrig1 positive stem cells could give rise to 
sebocytes. To investigate this in more detail, co immunofluorescence stainings of 
Lrig1 and Scd1 at different steps of HF formation were performed. The first 
sebocyte visible at stage 5 of HF morphogenesis arose adjacent to Lrig1 
expressing cells (Fig. 19 A). Furthermore, an increasing number of sebocytes 
was surrounded by Lrig1 positive cells. However, the sebocytes were Lrig1 
negative (Fig. 19 A, B). At stage 7 of HF morphogenesis, when the cluster of 
sebocytes splits up forming two individual glands, each cluster of Scd1 
expressing cells was enclosed by Lrig1 positive stem cells (Fig. 19 C, D).  
These data showed that sebocytes arise within the Lrig1 positive stem cell 
compartment.  
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Fig. 19) Sebocytes arise next to Lrig1 positive stem cells. A-D) Sections through epidermal 
whole mounts stained with Lrig1 (white) and Scd1 (magenta) shows that sebocytes (S) arise 
adjacent to Lrig1 expressing cells. SG = sebaceous gland. Scale bar: 20µm.  
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3.2.2) Lrig1 positive stem cells generate sebocytes by asymmetric 
cell fate decision 
 
The data suggested that Lrig1 positive stem cells give rise to sebocytes (Fig. 19). 
We hypothesised that Lrig1 positive cells underwent asymmetric cell fate 
decision to generate sebocytes. To test this, we have determined the orientation 
of mitotic spindles within this progenitor compartment. 
To visualise spindle orientation in cells of the HF, skin sections of K14NuMA-
GFP mice (Poulson and Lechler, 2010) were analysed for expression of NuMA, a 
marker of spindle poles. In this mouse model, NuMA-GFP is expressed under 
control of the K14 promoter. Therefore, it is present in all basal cells of the IFE, 
HF and SG, localising to the nucleus. In non-dividing cells, NuMA-GFP is 
localised diffusely within the nucleus. Once cells undergo division, NuMA-GFP 
expression is detected at the spindle poles of the dividing cell (Poulson and 
Lechler, 2010). We have analysed spindle orientation of mitotic cells at the upper 
part of the developing HF between P0 and P5 (Fig. 20).  
At least two scenarios of cell division can occur within the Lrig1 positive 
compartment. Orientation of the cell division axis in parallel to the basement 
membrane would lead to two Lrig1 positive stem cells and increase the cell 
compartment. If Lrig1 stem cells would divide perpendicularly to the basement 
membrane, one daughter cell could leave the basement membrane and 
differentiate towards the sebocyte lineage.  
Skin sections (n = 171) of K14NuMA-GFP mice were stained for GFP together 
with Scd1, Lrig1 or Laminin1 (Fig. 20) to analyse the orientation of the spindle 
poles. Laminin1 was used to determine spindle orientation in relation to the 
basement membrane. Spindle poles detected at the upper part of stage 5 to 
stage 7 HFs were quantified. The majority of cell divisions (84%) observed in 
Lrig1 positive cells occurred perpendicularly to the basement membrane. One 
spindle pole was oriented towards the basement membrane, the other pole 
pointed towards the Scd1 expressing sebocytes. Only 16% of the counted 
spindles were orientated in parallel to the basement membrane (Fig. 20 A, C).  
These data indicate that Lrig1 positive stem cells can give rise to Scd1 positive 
sebocytes by asymmetric cell fate decision.  
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Fig. 20) Lrig1 positive cells generate sebocytes by asymmetric cell fate decision. A) 
Analysis of skin sections of K14NuMA-GFP mice for orientation of mitotic spindles during SG-
development. NuMA-GFP (green, arrows) was costained with Laminin, Lrig1 or Scd1 (red) to 
visualize the cell type undergoing mitosis. Perpendicular spindle orientation (upper row, 
asymmetric cell fate) as well as parallel spindle orientation (lower row, symmetric cell fate) could 
be detected. B) Schematic drawing summarising symmetric and asymmetric cell fate within the 
Lrig1 progenitor compartment during SG morphogenesis. C) Quantification of perpendicular and 
parallel spindles detected within the Lrig1 compartment. n = 171 sections were counted. Scale 
bars: 20µm.   
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3.2.3) Proliferating Lrig1 positive cells give rise to sebocytes 
 
During development of the SG, expansion of the Scd1 positive compartment 
takes place. First, one Scd1 positive sebocyte is formed. Over time, a cluster of 
sebocytes develops that will finally split up forming two SGs. Proliferation via 
BrdU incorporation at the upper part of the HF was analysed to determine the 
cell compartment fuelling SG morphogenesis.  
Determination of the spindle pole orientation demonstrated that Lrig1 positive 
stem cells gave rise to sebocytes by asymmetric cell fate decision (Fig. 20, 
3.2.2). We wanted to analyse if the sebocytes themselves were able to 
proliferate and enlarge the cell cluster. Therefore, a 1h pulse of BrdU was given 
to mice (P 0 - P 2) and BrdU incorporation was analysed at different time points 
of development (Fig. 21).  
Analyses of the upper part of the HF at stage 5 of HF morphogenesis revealed 
that BrdU positive cells were detected within the Lrig1 positive compartment. In 
contrast, Scd1 positive sebocytes were BrdU negative. As the sebocyte cluster 
increased in size (stage 7 of HF morphogenesis), Scd1 positive cells remained 
BrdU negative, whereas BrdU/Lrig1 double positive cells were detected around 
the sebocytes. These data indicate that proliferating Lrig1 positive cells could 
give rise to sebocytes.  
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Fig. 21) Lrig1 positive cells proliferate to generate sebocytes. Colocalisation of Lrig1 (grey, 
left image) and BrdU (green) at stage 5 (upper and middle row) and 7 (lower row) of HF 
morphogenesis reveals that proliferation occurs in the Lrig1 positive compartment (arrows) and 
not in Scd1 positive cells (magenta, arrowheads). S, sebocytes; SG, sebaceous gland. Scale 
bars: 20µm.  
 
To determine whether Lrig1 positive cells indeed gave rise to Scd1 positive 
sebocytes, short term EdU pulse-chase experiments were conducted. EdU 
incorporation was analysed at 1h and 48h of chase (Fig. 22). After 1h, EdU 
positive cells were seen within the Lrig1 positive compartment, whereas Scd1 
positive cells remained EdU negative (Fig. 22 A, B). After 48 h, a weaker EdU 
label could also be detected in Scd1 positive sebocytes (Fig. 22 B, D). This 
indicates that Lrig1/EdU double positive cells proliferated thereby diluting the 
label out and giving rise to Scd1 positive sebocytes. Statistical analyses (Fig. 22 
E) revealed that none of 233 counted HFs (n=3 mice) contained Scd1/EdU 
double positive cells after 1h EdU pulse. However, after 48h, 305 HFs 
comprising Scd1/EdU double positive cells (n=3 mice) could be detected. These 
data demonstrate that Lrig1 positive cells were initially labelled with EdU. The 
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EdU label was diluted out by proliferation of Lrig1 positive cells giving rise to 
sebocytes. 
 
 
Fig. 22) Lrig1 positive cells proliferate and give rise to sebocytes. EdU labelling shows that 
initially, Scd1 positive cells (green in C) are negative for EdU-incorporation (red) (A, C). Note that 
Lrig1 positive cells (green in C and D) surrounding the SG incorporated EdU (red arrow). When 
chased for 48 h Scd1/EdU double positive cells (red arrowhead) and EdU positive cells (red 
arrow) were detected (B, D). E) Quantification of HFs with Scd1/EdU double positive cells at 1 h 
and 48 h after EdU pulse (n = 3 mice). Insets are enlargements of the SG. SG = sebaceous 
gland. Scale bars: 20µm.  
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3.3) Origin of cells forming HF and SG 
 
One emerging issue in the field of skin biology is to identify the origin of cells 
generating the SG. Recently, it was demonstrated that early HF stem cells 
marked by the expression of Sox9 were required for the formation of the SG. In 
the absence of Sox9, neither HF stem cells nor SGs were formed (Nowak et al., 
2008).The data presented in this thesis analysing Sox9 and Lrig1 expression 
suggested that HFs and SGs are formed by the same precursor cells during 
morphogenesis. To further investigate the origin of cells forming HFs and SGs, 
we have performed lineage tracing analysis during epidermal morphogenesis. 
During adult homeostasis of HFs and SGs, stem cells of the bulge region 
regenerate the HF in a cyclic fashion (Schneider et al., 2009). Bulge stem cells 
have also been proposed to be the source for cellular renewal of the SG 
(Blanpain et al., 2004; Morris et al., 2004; Taylor et al., 2000). Recently; our 
group has provided strong evidence supporting this model (Petersson et al., 
2011). Mice expressing inducible Cre recombinase under control of the K15 
regulatory promoter sequence in bulge stem cells (AK15CreER(G)T2-mice) were 
crossed to R26REYFP reporter mice (Srinivas et al., 2001). Application of low 
doses of Tamoxifen leads to activation of Cre recombinase in 1-3 bulge stem 
cells. Excision of a stop cassette in front of the YFP gene leads to constitutive 
YFP expression in cells with active Cre and all descendents of these cells (Fig. 
6). Therefore, the progeny of initially labelled bulge stem cells can be traced. It 
was demonstrated that bulge derived progeny reconstitute HF and SGs 
(Petersson et al., 2011). Interestingly, it was previously shown that the promoter 
fragment used for the generation of AK15CreER(G)T2- mice was already active 
during early postnatal morphogenesis (Liu et al., 2003). Moreover, expression of 
K15 protein was detectable as early as E15.5 in mouse epidermis (Nöbel, 2009). 
Therefore, we hypothesised that the K15 promoter fragment could already be 
active at E15.5 in the epidermis. The facts that K15 derived progeny contribute to 
SG regeneration and that the K15 promoter is active before the initiation of SG 
formation made our mouse model useful for lineage tracing approaches during 
early HF and SG morphogenesis. Applying AK15CreER(G)T2/R26REYFP-mice 
we aimed to analyse if the K15 positive cell population was already active during 
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HF morphogenesis and could serve as an important cellular source for the 
formation of the SG.  
 
3.3.1) Individual cells are labelled in tail IFE upon embryonic Tam 
treatment  
 
To label individual epidermal cells at early stages of HF morphogenesis, 
pregnant female AK15CreER(G)T2/R26REYFP mice were injected i.p. with one 
single dose of 2mg Tam at E16.5. In this initial approach, we focussed on the 
analysis of YFP labelled cells and their progeny in tail epidermis. 
To analyse the number of initially labelled cells, mice were prepared one or two 
days following Tam treatment (E17.5 or E18.5). Our initial data show that one 
day after Tam injection, almost no YFP expression was detected in tail epidermis 
of E17.5 embryos (Fig. 23 B). At E18.5 (two days following Tam treatment), YFP 
positive cells could be clearly identified (Fig. 23 C). This duration of Cre 
recombinase activation is consistent with previous reports using this particular 
Cre line (Petersson et al., 2011). As shown in Fig. 23 C, individual epidermal 
cells were labelled. Moreover, groups of two or three YFP positive cells were 
seen in close proximity to each other. One possible explanation would be that 
neighbouring cells randomly responded to Tamoxifen treatment individually. 
Another possibility is that one cell was labelled, divided and gave rise to 
daughter cells. Importantly, only cells in the epidermis were initially labelled and 
no positive cells could be detected in the already established placodes of the 
central HF. Thus, the experiments reveal that the K15 promoter fragment used to 
drive inducible Cre expression is already active at E16.5 in basal keratinocytes of 
the IFE.  
So far, for each time point, three embryos of two different litters were analysed 
and similar results could be observed. To characterise the amount and 
distribution of labelled YFP positive cells in more detail, statistical analyses are 
currently performed. 
However, the data show that individual cells could be targeted within the 
epidermis and this protocol is applicable to track YFP positive progeny during 
morphogenesis. 
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Fig. 23) Targeting of epidermal cells using AK15CreER(G)T2 mice. A) Timeline of Tamoxifen 
application and tissue harvesting. B-C) YFP-detection in epidermal cells at E17.5 (B) and E18.5 
(C). Arrows point to YFP positive nuclei (B) and to individually labelled cells (C). Arrowheads 
point to small clusters of YFP positive cells. Dashed lines mark placodes of central HFs. Scale 
bar 50 µm. 
 
3.3.2) Cells originating in the IFE contribute to HF and SG formation 
 
To investigate whether individual YFP cells derived from the IFE contribute to 
formation of HFs and SGs, lineage tracing experiments were conducted. 
Therefore, later tracing time points were analysed. Tam was given at E15.5 or 
E16.5 to pregnant female mice and the pups were prepared at different time 
points shortly after birth.  
Initial data suggest that labelled K15 positive cells first expanded within the 
epidermis. Three or four days after Tam treatment, larger YFP positive cell 
clusters could be detected (Fig. 24 B). Five to seven days following Tam 
treatment, YFP positive cells could also be detected in the developing HFs (Fig. 
24 D). To characterise the distribution and localisation of labelled cell clusters in 
more detail, we have quantified the localisation of YFP positive cells within the 
pilosebaceous unit four to ten days after Tam treatment. Therefore, three 
different labelling patterns were defined. We grouped HFs with labelled cells at 
the upper part, not reaching below the SGs (termed SG). A second group 
comprised HFs only containing labelled cells beneath the SG (termed HF). HFs 
containing cells in both parts were summarised in the third group (SG/HF).  
The majority of primary (central) HFs with YFP positive cells could be classified 
in “SG”. In these HFs, we could detect YFP positive cells surrounding Scd1 
positive sebocytes (Fig. 12 D). Importantly, we also observed colocalisation of 
YFP and Scd1 in sebocytes (Fig. 12 K). To strengthen these observations, co 
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immunofluorescence stainings for Lrig1 and YFP are currently performed to 
analyse if K15 derived progeny contributes first to the Lrig1 positive compartment 
before generating sebocytes.  
In secondary (side) HFs that had only reached stage 2 or 3 of HF 
morphogenesis, it was more difficult to distinguish between the SG and the HF 
pattern. Here, labelled cells localised more randomly distributed within the HG or 
bulbous peg (Fig. 24 C). Accordingly, most of the secondary HFs were counted 
in the SG/HF pattern. HFs displaying labelling according to the “HF” pattern were 
observed to a much lesser extent than the two other labelling patterns. This 
suggests that K15 derived progeny derived from the IFE preferentially localise to 
the SG and only occasionally contribute to the formation of HF. To strengthen 
these initial data, detailed statistical analyses will be performed. Moreover, co 
immunofluorescence stainings with markers specifically expressed in different 
regions of the developing HF will be performed. Thus we will be able to quantify 
contribution of K15 derived progeny to distinct regions within the HF.  
To follow the fate of the cells labelled in the IFE, we have analysed tail skin of 
mice traced for a longer period of time. Analysing HF nineteen days after Tam 
treatment (at E15.5 or E16.5) demonstrates that K15 derived progeny can still be 
detected. Classifying the labelled HFs according to the above mentioned 
patterns revealed that an important part of the labelled HFs were among the 
“SG” pattern (Fig. 24 E, F). However, we also observed HF with YFP positive 
cells exclusively localising beneath the SG (“HF” pattern). More rarely, HFs with 
labelled cells in HF and SGs were detected (Fig. 24 G). In order to statistically 
evaluate the results obtained so far, more animals will be analysed in the near 
future. Our initial data strongly suggest that cells of the SG derive from the IFE 
and that HF and SG might be formed by different cell populations.  
 
We have also labelled cells at E17.5, when most placodes, at least of the central 
HFs, are already established (Fig. 24 I-K). Similar to the results obtained before, 
we detected expansion of labelled cells in the IFE at two days of tracing (Fig. 24 
J). When tracing was performed for seven to ten days, YFP positive cells were 
also detected within the HFs, mostly in the upper part. Importantly, clonal 
expansion of YFP positive cells from the IFE towards the SG was detected (Fig. 
24 K, L).  
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Taken together, these initial data indicate that cells derived from the IFE 
contribute to HF and SG formation even after placode formation has occurred. 
The fact that a considerable amount of HFs contained labelled cells only at the 
upper part of the HF, not below the SG indicates that K15 derived progeny 
originating in the IFE contributes to the formation of the SG. In a majority of HFs 
with YFP positive cells in the “SG” pattern no YFP positive cells were detected in 
the HF. Therefore, it is tempting to speculate that progenitor cells of the IFE are 
specifically recruited to form the SG and most likely the Lrig1 positive stem cell 
compartment as well. This would provide a novel mechanism into the process of 
the formation of the SG.  
 
Fig. 24) Lineage tracing of IFE cells contributing to SG-development. A-G) Tracing of K15 
derived progeny from E16.5 to P15. H) Oil control, I-K) Tracing of K15 derived progeny from 
E17.5 to P8. A, I) Timeline of Tamoxifen treatment and duration of tracing. B-H, J-K) 
Immunostaining of YFP (green) and Scd1 (red) on epidermal whole mounts isolated at different 
tracing time points. Note clonogenic expansion of labelled cells (arrowheads in B-F and I-K). Note 
bulge region (B) and sebaceous glands (SG) containing YFP-labelled cells in telogen HFs. Oil 
control (H) is clean. Scale bars: 50µm.  
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3.3.3) K15 derived progeny display high proliferative capacity in vitro 
 
Together with previous results obtained in our laboratory, our initial lineage 
tracing experiments of K15 derived progeny during skin morphogenesis imply 
that the labelled YFP positive cells can give rise to different cell types. To 
evaluate labelled K15 positive cells of the IFE for their proliferative potential a 
colony forming assay was performed in vitro (Barrandon and Green, 1987; 
Jensen et al., 2010). In principle, a defined number of cells is plated and 
formation of colonies is followed for several weeks. In general, stem cells having 
a high proliferative capacity, form more large colonies than transit amplifying 
cells.  
In order to investigate the proliferative capacity of K15 expressing cells and 
immediate progeny, we have isolated YFP positive cells at early postnatal stages 
of skin development. To obtain a sufficient amount of YFP labelled cells, another 
line of the K15CreER(G)T2 mice was applied (CK15CreER(G)T2). In this mouse 
line, more cells are labelled initially upon Tam treatment (Petersson et al., 2011). 
Prior isolating YFP positive cells, it was confirmed that initially YFP labelled 
keratinocytes were only detected in the IFE and not in the placodes (data not 
shown).  
To perform the colony forming assay, embryos were treated intra uterally at 
E15.5 or E16.5 as for the lineage tracing experiments described before. YFP 
positive keratinocytes were isolated at day 5 of tracing (see 2.6.1). To increase 
the number of cells, back and tail skin of all pups from one litter were pooled. In 
order to purify basal epidermal cells, staining for Itgα6 was performed (2.6.3). 
Epidermal cells were FAC-sorted for strong YFP signal and high Itgα6 
expression (Itgα6high / YFPpositive). As negative control, Itgα6high / YFP negative 
cells were sorted (Fig. 25 A). 3000 YFP positive/Itgα6high and 
YFPnegative/Itgα6high epidermal cells were plated in triplicates on collagen 
coated culture dishes containing growth-inhibited fibroblasts (2.6.4). Additionally, 
6000 and 10000 were plated as well.  
Four weeks following cultivation cells were fixed and stained. Colonies were 
counted and the colony forming efficiency (CFE) was calculated (number of 
colonies/number of plated cells in %). Interestingly, CFE of YFP positive cells 
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was higher compared to YFP negative populations. This implies that YFP 
positive cells have a stronger ability to form colonies in vitro than YFP negative 
cells (Fig. 25. C, D). This indicates that YFP positive cells have a better capacity 
to attach to the collagen via integrins. It has been shown in human keratinocytes 
that enhanced adhesion is due to higher β1-Integrin expression and this also 
correlates with higher proliferative capacity (Jones and Watt, 1993; Jones et al., 
1995). However, the overall number of colonies formed by 3000 YFP positive 
cells was very low but more colonies were formed by YFP positive cells 
compared to YFP negative cells. When plating 6000 and 10000 cells, the CFE 
was higher and YFP positive cells formed more colonies than equal numbers of 
seeded YFP negative cells. To evaluate the proliferative potential of the plated 
cells we have also compared the size of colonies formed by 6000 or 10000 
seeded cells (Fig. 25 E). Initial data suggest that a higher number of larger 
colonies is formed by YFP positive cells than by YFP negative cells. The 
percentage of small, abortive colonies was higher in YFP negative cells 
compared to YFP positive cells. To strengthen the data obtained so far and to 
perform statistical analysis, the assay will be repeated.  
Taken together, this initial approach investigating colony forming potential of K15 
derived progeny suggests that these cells have a higher proliferative capacity 
and form more colonies in vitro.  
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Fig. 25) YFP-positive cells have a higher potential to form colonies in vitro. A) FACS-plot of 
sorting procedure showing YFP positive (P7) and YFP negative (P6) cells. Note that Oil control is 
clean, not containing YFP+ cells in P7. B) YFP-expression in keratinocyte colonies. C) Cristal 
violet stained keratinocyte colonies from FACS-sorted YFP positive and YFP negative cells. D) 
Plotted colony forming efficiency of YFP positive and YFP negative cells. E) Evaluation of the 
colony size formed by YFP positive and negative cells. Scale bar 100µm 
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3.4) Influence of Rac1 on sebocyte differentiation in skin tumours  
 
Together with the results of other groups, we have shown that HF stem cell 
populations implicated in the regeneration of the SG during adulthood also play a 
role in the development of this organ (Frances and Niemann, 2012; Nowak et al., 
2008). It has been demonstrated that these stem and progenitor compartments 
are also established during ectopic SG development (Petersson et al., 2011). 
This appears in mice expressing N- terminally truncated Lef1 under the control of 
the K14 promoter (K14ΔNLef1 mice, (Niemann et al., 2007; Niemann et al., 
2002)). In K14ΔNLef1 mice, spontaneous, well differentiated sebaceous 
adenomas, sebeomas and squamous papillomas with sebocyte differentiation 
are formed (Niemann et al., 2002). These non-invasive, benign tumours can also 
be induced upon treatment with DMBA (Niemann et al., 2007). 
In addition, the small GTPase Rac1 was previously shown to be crucial for 
proper maintenance of the HF stem cell compartment (Benitah et al., 2005; 
Chrostek et al., 2006). Activated Rac1 lead to an expansion of cells capable of 
clonal growth in vitro (Benitah et al., 2005). This indicates a potential role for 
Rac1 in regulating stem cell behaviour.  
To investigate the effect of activated Rac1 on tumour formation, K14ΔNLef1 
mice were crossed to mice expressing L61Rac1, a constitutively active variant of 
the small GTPase Rac1 in epidermal cells (Tscharntke, 2006). After treatment 
with the carcinogen DMBA, K14ΔNLef1/L61Rac1 mice developed sebaceous 
adenomas, sebeomas and squameous papillomas like the K14ΔnLef1 mice. 
Interestingly, also less differentiated tumours were observed (Tscharntke, 2006).  
To address the role of Rac1 in tumour growth, histology and invasiveness, we 
have analysed skin tumours of mice expressing K14ΔNLef1 and K14L61Rac1 in 
epidermal cells in more detail. K14ΔNLef1/L61Rac1 mice were compared to 
K14ΔNLef1 mice. We have investigated if expression of activated Rac1 in 
tumours lead to alterations in the stem cell compartments. Therefore, expression 
of HF progenitor markers in addition to sebocyte differentiation markers was 
analysed within the tumours. 
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3.4.1) L61Rac1 alters proliferation and sebocyte differentiation in skin 
tumours  
 
The incidence and frequency of skin tumours did not vary much between 
K14ΔNLef1/L61Rac1 and K14ΔNLef1 mice. L61Rac1 control mice did not form 
tumours (Tscharntke, 2006). The majority of the tumours of K14ΔNLef1/L61Rac1 
mice were sebaceous adenomas and squamous papillomas with sebocyte 
differentiation (Fig. 26). However, some of the tumours developing in 
K14ΔNLef1/L61Rac1 mice showed an altered histology with a more 
undifferentiated character (Fig. 26).  
Previously, it has been shown that K14ΔNLef1-mice developed well 
differentiated benign sebaceous adenomas with lobules comprising an outer, 
proliferative layer of keratinocytes and differentiated sebocytes in the centre of 
the lobules (Niemann et al., 2007). To compare sebocyte differentiation and 
proliferation in K14ΔNLef1- and K14ΔNLef1/L61Rac1 mice, co 
immunofluorescence stainings for Scd1 and BrdU were carried out (Fig.26 A). 
Indeed, the K14ΔnLef1-adenomas showed well organized tumour lobules filled 
with Scd1 positive sebocytes. BrdU incorporating basal cells were detected at 
the periphery of the well organised sebocyte lobules (Fig. 26 E).  
K14ΔNLef1/L61Rac1 mice also formed well differentiated sebaceous adenomas 
with differentiated sebocytes in the centre and undifferentiated proliferating basal 
cells at the periphery of the tumour lobules (Fig. 26 B, F). Tumours of 
K14ΔNLef1/L61Rac1 mice that were classified as sebeomas showed less 
sebocyte differentiation and BrdU positive cells were not always confined to the 
layer of basal keratinocytes surrounding the sebaceous lobules of the tumours 
(Fig. 26 C, G). These tumours also contained regions with more squamous 
differentiation (data not shown). Another type of tumours detected in 
K14ΔNLef1/L61Rac1 mice showed a very different histology. Major parts of the 
tumour consisted of very small, densely packed cells (Fig. 26 D). Hardly any 
differentiated sebocyte expressing Scd1 could be detected in these tumours. In 
contrast, BrdU positive cells were distributed over the tumour mass (Fig. 26 H). 
These tumours did not display the well organised lobular structure of an 
adenoma anymore and were therefore referred to as K14ΔNLef1/L61Rac1 
carcinoma.  
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Fig. 26) Histology and proliferation of sebaceous tumours. A-D) Hematoxylin and Eosin 
stained sections of tumour tissue from K14ΔNLef1 and K14ΔNLef1/L61Rac1 -mice. E-H) 
Immunostaining to analyse expression of Scd1 (red), BrdU (green) in sections of skin tumours. 
Arrows point to proliferating cells, Scale bars: 50µm 
 
The fact that some of the K14ΔNLef1/L61Rac1 tumours displayed an 
undifferentiated histology lead to the hypothesis that the expression of activated 
Rac1 in tumours of K14ΔNLef1 mice triggered expansion of HF progenitor cells 
at the expense of sebocyte differentiation. Moreover, sebocyte differentiation 
could be blocked. To test this, expression of HF progenitor and sebocyte 
differentiation markers was analysed on transcriptional and protein level, 
summarised in Table 14 (Sharma, 2011). Overall, immunofluorescence stainings 
revealed a decrease of sebocyte differentiation markers such as Scd1 and 
Adipophilin in K14ΔNLef1/L61Rac1 sebeomas and K14ΔNLef1/L61Rac1 
carcinomas compared to K14ΔNLef1- or K14ΔNLef1/L61Rac1 adenomas. This 
result could be verified on a molecular level by conducting qRT-PCR. Also on 
transcriptional level, Scd1 expression was decreased in K14ΔNLef1/L61Rac1 
carcinomas and sebeomas versus K14ΔNLef1/L61Rac1 and K14ΔNLef1 
adenomas. In contrast, an increase of the HF progenitor marker MTS24/Plet1 
could be identified in K14ΔNLef1/L61Rac1 sebeomas and carcinomas compared 
to K14ΔNLef1/L61Rac1 adenomas and K14ΔNLef1 adenomas by antibody 
staining. Stem cell marker Lrig1 was analysed on transcriptional level. Lrig1 
expression was moderately elevated in K14ΔNLef1/L61Rac1 carcinomas 
compared to K14ΔNLef1/L61Rac1 adenomas and K14ΔNLef1 adenomas. Itgα6, 
a marker expressed by basal epithelial cells was slightly down regulated on 
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protein level in K14ΔNLef1/L61Rac1 sebeomas and K14ΔNLef1/L61Rac1 
carcinomas.  
Taken together, these data indicate that sebocyte differentiation markers were 
down regulated in K14ΔNLef1/L61Rac1 carcinomas whereas HF progenitor 
markers were up regulated.  
 
Table 14) Analysis of progenitor and sebocyte differentiation marker expression in 
sebaceous tumours  
Tumour type 
SG differentiation marker Progenitor marker 
Scd1 Adipo-
philin 
Protein 
Plet1 
Protein 
Itgα6 
Protein 
Lrig1 
Trans-
cription Protein Transcription 
K14ΔNLef1/ 
adenoma +++ +++ +++ + +++ + 
K14ΔNLef1/ 
L61Rac1 
adenoma 
+++ +++ +++ + +++ + 
K14ΔNLef1/ 
L61Rac1 
sebeoma 
++ n.d. ++ ++ ++ n.d. 
K14ΔNLef1/ 
L61Rac1 
carcinoma 
+ + + ++ + ++ 
+++ = strong expression, ++ = medium expression, + = weak expression, n.d. = not determined 
 
3.4.2) Isolation and transcriptional profiling of distinct cell populations 
from sebaceous tumours 
 
Some of the K14ΔNLef1/L61Rac1 tumours showed less sebocyte differentiation 
and enhanced expression of HF progenitor markers compared to other 
K14ΔNLef1/L61Rac1 tumours. Potentially, the small, densely packed cells of the 
K14ΔNLef1/L61Rac1 carcinomas were undifferentiated sebocytes that were 
unable to undergo maturation. Besides this, it would be possible that gene 
expression in the K14ΔNLef1/L61Rac1 carcinoma cells was altered. To identify 
potential candidate genes responsible for maintaining the cells in an 
undifferentiated state, we analysed the transcriptional profile of different tumour 
cell populations. Transcription profiles of basal cells and mature sebocytes of the 
K14ΔNLef1/L61Rac1 adenomas were compared to profiles of undifferentiated 
cells from K14ΔNLef1/L61Rac1 carcinomas.  
To isolate distinct tumour cell populations, laser capture micro dissection 
approach was employed. In a first set of experiments, a pilot approach was 
conducted assuring accuracy of the method (see 2.4). Therefore, individual cell 
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populations were isolated from skin sections by laser capture micro dissection. 
RNA was isolated and reversely transcribed into cDNA (see 2.5.5). We have 
analysed marker expression by RT-PCR. Cells isolated from SGs expressed 
Scd1 but did not express K19, known to be expressed by the HF exclusively. 
Also, SG-derived tissue did not show expression of Vimentin, a marker of the 
adjacent dermal cells (Fig. 10, Materials and Methods). Therefore, we concluded 
that micro dissection was precise enough to isolate distinct cell populations.  
To compare transcriptional profiles of tumour cells, three different cell 
populations were isolated from the K14ΔNLef1/L61Rac1 tumours (Fig. 27). Basal 
cells and mature sebocytes were cut out from K14ΔNLef1/L61Rac1 adenomas 
(Fig. 27 A-D and E-H) and areas of undifferentiated cells were captured from 
K14ΔNLef1/L61Rac1 carcinomas (Fig. 27 I-L). Areas comprising 10-100 cells 
were isolated. 
To determine the transcriptional profiles of the isolated cell populations, cDNA 
libraries were generated from 10 tissue samples of each cell type (see 2.5.6). 
Therefore, a novel method allowing analysing the transcriptional profile of one 
single cell was applied (in collaboration with the group of Christoph Klein, 
Regensburg, Germany). This approach involves isolation of mRNA and reverse 
transcription into cDNA. To amplify the amount of cDNA, PCR is conducted 
maintaining the relative expression levels of transcribed genes. Gene expression 
profiles of the different isolated cell populations were generated by 
oligonucleotid-arrays in collaboration with the group of Christoph Klein.  
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Fig. 27) Microdissection of distinct tumour cell populations. Basal cells (B) (A-D) and 
sebocytes (S) (E-H) from K14ΔNLef1/L61Rac1 adenomas and undifferentiated cells (U) (I-L) 
from K14ΔNLef1/L61Rac1 carcinomas have been isolated. Area of interest has been marked 
(red line in B, F, J). Laser cuts along the marked line (C, G, K) and piece of tissue is catapulted 
into collection tube (arrows in D, H, L). Scale bars: 50 µm.  
 
The expression profiles of basal cells, sebocytes and undifferentiated cells were 
compared to each other (in collaboration with the group of C. Klein, Regensburg, 
Germany). Differentially regulated genes were identified between basal cells and 
undifferentiated cells and sebocytes and undifferentiated cells. Table 15 
summarises a selection of differentially regulated genes. Most of the genes listed 
in this table are associated with the lipid metabolism such as Scd1 or Elovl3 and 
4. The majority of these genes was down regulated in undifferentiated cells 
captured from K14ΔNLef1/L61Rac1 carcinoma compared to basal cells and 
sebocytes isolated from K14ΔNLef1/L61Rac1 adenomas. This indicates a 
change in the gene expression profile in cells of the K14ΔNLef1/L61Rac1 
carcinoma. A complete list of all significantly regulated genes can be found in the 
annex of this thesis (see 11). Interestingly, the differences detected between 
sebocytes and basal cells were not statistically significant. The majority of the 
genes up regulated in sebocytes compared to undifferentiated cells were also up 
regulated in basal cells compared to undifferentiated cells. This indicates that 
genes necessary for differentiation towards the sebocyte lineage are already 
                                                                                                              Results 
75 
expressed when the cells are still in an undifferentiated state. Thus, basal cells of 
adenoma lobules are already committed towards their cell fate.  
 
Table 15) Significantly regulated genes associated with lipid metabolism (in sebocytes 
and basal cells versus undifferentiated cells) derived from K14ΔNLef1/L61Rac1 mice 
Gene symbol 
Log2fc (compared to 
undifferentiated cells) description 
Sebocytes Basal cells 
Elovl4 6,165 5,182 Elongation of very long chain fatty acids-like 4 
Elovl3 5,661 4,716 Elongation of very long chain fatty acids-like 3 
Psapl1 4,409 3,082 Prosaposin-like 1 
Dhcr24 
(Seladin-1) 3,901 3,137 24-dehydrocholesterol reductase 
Adfp 3,306 1,76 (ns*) Adipose differentiation related protein (Adipophilin) 
Nupr1 3,227 - Nuclear protein 1 
Scd1 3,117 3,532 Stearoyl-Coenzyme A desaturase 1 
Dgat2l6 3,027 - Diacylglycerol O-acyltransferase 2-like 6 
Pnpla5 2,846 - Patatin-like phospholipase domain containing 5 
Elovl6 1,534 (ns*) 3,522 Elongation of very long chain fatty acids-like 6 
Apoa2 - -2,991 Apolipoprotein A-II 
*) ns = not significant; positive values signify up regulation of genes, negative values signify down 
regulation 
 
3.4.3) Verification of selected candidate genes  
 
The expression of the differentially regulated genes detected in the oligo 
nucleotide-arrays was validated by qRT-PCR. CDNA libraries applied in the array 
were used to verify the gene regulation. In addition, further cDNA libraries were 
generated from basal cells and sebocytes captured from K14ΔNLef1/L61Rac1 
adenoma and undifferentiated cells isolated from K14ΔNLef1/L61Rac1 
carcinoma (2.4 and 2.5.6). Fig. 28 shows exemplary results of qRT-PCR 
analyses. The validation results of selected candidate genes are presented in the 
following chapters.  
In addition, we have identified interesting candidate genes playing a role in 
different biological functions. For example, Gankyrin has been associated with 
cell cycle regulation (Lozano and Zambetti, 2005). Another promising candidate 
gene is Prominin2, related to Prominin1, which is established as a marker for 
renal or prostatic epithelial stem cells (Bussolati et al., 2005; Fargeas et al., 
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2003; Richardson et al., 2004). In the future, we will analyse the role of these 
interesting candidates in more detail.  
 
 
Fig. 28) Verification of selected candidate genes. A-C) qRT-PCR results verifying regulation of 
Scd1(TagMan-assay), Elovl3 and 4 (SYBR-green assay) in basal cell, sebocytes and 
undifferentiated cells of K14∆nLef1/KL161Rac1-tumours. D, E) qRT-PCR results (TaqMan-
assay) verifying regulation of Dhcr24 and Nupr1 in basal cells, sebocytes and undifferentiated 
cells of K14∆nLef1/KL161Rac1-tumours. 
 
3.4.3.1) Down regulation of Scd1, Elov3 and Elovl4 in cells of 
K14ΔNLef1/L61Rac1 carcinoma 
 
We have analysed expression levels of genes known to be involved in the lipid 
metabolism of sebocytes as Scd1 and Elovl3 (Binczek et al., 2007; Miyazaki et 
al., 2001; Westerberg et al., 2004). Elovl4 was previously shown to play a role in 
skin barrier function (Cameron et al., 2007; Li et al., 2007). 
Applying TaqMan or SYBR green assays, the regulation of Scd1, Elovl3 and 
Elovl4 as determined in the micro array could be confirmed. Our qRT-PCR 
results showed very low expression of Scd1, Elovl3 and Elovl4 in most of the 
samples isolated from K14ΔNLef1/L61Rac1 carcinomas (Fig. 28 A, B, and C). In 
the basal cells isolated from K14ΔNLef1/L61Rac1 adenomas, all of the tested 
genes were expressed to a lesser extent than in the sebocytes from the same 
tumours (Fig. 28). This shows that genes necessary for lipid metabolism of 
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sebocytes are already expressed, although to a lesser extent, when the cells are 
not fully differentiated.  
Gene expression of Scd1 was also analysed using RNA isolated from whole 
tumour lysates (Sharma, 2011). Expression levels of Scd1 were significantly 
down regulated in tumours classified as K14ΔNLef1/L61Rac1 carcinomas 
compared to K14ΔNLef1/L61Rac1 adenomas. Furthermore, protein expression 
of Scd1 was analysed by western blot. Scd1 protein expression was strongly 
reduced in K14ΔNLef1/L61Rac1 carcinomas compared to K14ΔNLef1 
adenomas and K14ΔNLef1/L61Rac1 adenomas. Interestingly, the amount of 
Scd1 protein was also reduced in K14ΔNLef1/L61Rac1 adenomas compared to 
K14ΔNLef adenomas. Taken together, these data indicate that micro array 
results for Scd1, Elovl3 and Elovl4 were reproducible. Furthermore, the results 
suggest that sebocyte maturation is inhibited in K14ΔNLef1/L61Rac1 carcinomas 
due to changes in the gene expression profile.  
 
3.4.3.2) Decreased expression of 24-Dehydrocholesterol-reductase 
in K14ΔNLef1/L61Rac1 tumours 
 
Furthermore, we were interested in verifying and further analysing the 
expression of 24-Dehydrocholesterol-reductase (Dhcr24, Seladin-1) in 
K14ΔNLef1/L61Rac1 tumours. Dhcr24 is an enzyme catalysing the conversion of 
desmosterol to cholesterol (Waterham et al., 2001). It was shown to be up 
regulated on transcriptional level in early stages of prostate cancer. In 
progressed stages and metastases of prostate cancer Dhcr24 expression was 
down regulated (Battista et al., 2010; Hendriksen et al., 2006). To verify 
expression of Dhcr24 in the cell populations isolated from K14ΔNLef1/L61Rac1 
adenomas and carcinomas, qRT-PCR was performed. Indeed, Dhcr24 mRNA 
was up regulated in sebocytes and basal cells isolated from 
K14ΔNLef1/L61Rac1 adenomas whereas it was down regulated in cells isolated 
from K14ΔNLef1/L61Rac1 carcinomas. Analysing gene expression in whole 
tumour lysates showed similar results. Tumours classified as 
K14ΔNLef1/L61Rac1 adenomas displayed elevated expression of Dhcr24 
compared to tumours identified as K14ΔNLef1/L61Rac1 carcinomas. 
Interestingly, Dhcr24 gene expression was significantly higher in K14ΔNLef1 
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adenomas (Sharma, 2011). However, on the protein level, Dhcr24 expression 
was not changed between K14ΔNLef1/L61Rac1 adenomas and 
K14ΔNLef1/L61Rac1 carcinomas. Both tumour types showed low expression of 
Dhcr24. Nevertheless, K14ΔNLef1 adenoma showed higher Dhcr24 protein 
levels than K14ΔNLef1/L61Rac1 tumours, consistent with the results obtained on 
gene expression level (Sharma, 2011). This indicates that Dhcr24 expression 
decreases in sebaceous tumours with aberrant expression of activated Rac1. 
The fact that Dhcr24 expression is already down regulated in benign 
K14ΔNLef1/L61Rac1 adenomas, some of which progressed into carcinomas, 
suggests Dhcr24 as a potential indicator for tumours susceptible to progress into 
undifferentiated tumours like carcinomas. Another possibility is that down 
regulation of Dhcr24 favours the progression of adenomas into carcinomas In the 
future, it will be interesting to further characterise the role of Dhcr24 in skin 
tumour progression. 
 
3.4.3.3) Reduced Nuclear protein1 expression in cells of 
K14ΔNLef1/L61Rac1 carcinoma 
 
Next, expression of Nuclear protein1 (Nupr1, also known as P8 or Com1) was 
validated. Nupr1 was previously shown to play a role in the cellular stress 
response (reviewed in (Goruppi and Iovanna, 2010)). Moreover, opposing 
studies were published about the role of Nupr1 in tumour biology. It was reported 
that Nupr1 can act as a tumour promoter also mediating metastasis in breast 
cancer cells (Ree et al., 2000; Ree et al., 1999). In contrast, analyses of prostate 
cancer suggested a tumour suppressive function for Nupr1 (Jiang et al., 2006a; 
Jiang et al., 2006b). So far, Nupr1 has not been implicated in formation of skin 
tumours. The contradictory roles of Nupr1 in tumour biology and the fact that it 
was not yet described to play a role in skin cancer lead us to analyse Nupr1 
expression in more detail. 
The results of the oligo nucleotide array suggested a down regulation of Nupr1 in 
cells isolated from K14ΔNLef1/L61Rac1 carcinomas compared to sebocytes 
from K14ΔNLef1/L61Rac1 adenomas. In basal cells from K14ΔNLef1/L61Rac1 
adenoma, Nupr1 was not detected in the array. Our qRT-PCR analyses of Nupr1 
expression in more cDNA libraries confirm these data (Fig. 28 C). However, low 
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expression of Nupr1 could be detected in two out of five cDNA libraries from 
basal cells (K14ΔNLef1/L61Rac1 adenoma). Analysis of Nupr1 expression in 
RNA isolated from whole K14ΔNLef1/L61Rac1 tumour lysates suggested a down 
regulation of the gene in K14ΔNLef1/L61Rac1 carcinomas. This is in line with the 
Nupr1 expression in distinct cell populations isolated from K14ΔNLef1/L61Rac1 
tumours. However, the results obtained from whole tumour lysates were not 
statistically significant due to the heterogeneity of the tumour material and will 
therefore be further investigated in the future (Sharma, 2011).  
 
Taken together, we have compared expression profiles of three different cell 
populations from differentiated and undifferentiated skin tumours applying oligo 
nucleotide arrays. The results obtained from the arrays were reproducible. We 
have identified differentially regulated genes that were previously shown to play 
a role in tumour formation. To date, Dhcr24 and Nupr1 have not been associated 
with tumour formation in the skin. It will therefore be interesting to further 
characterise their function in tumour development.  
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4. Discussion 
 
HFs and SGs are the two integral parts of the pilosebaceous unit in mammalian 
skin. HFs are regenerated throughout adult life by stem cells (Blanpain and 
Fuchs, 2009; Hardy, 1992). More recently, it was demonstrated that HF stem 
cells not only regenerate the HF but are also implicated in the regeneration of the 
SG (Petersson et al., 2011; Taylor et al., 2000). Moreover, there is evidence that 
HF stem cells are specified during HF morphogenesis. These stem cells were 
shown to be necessary for proper development of the HF stem cell niche (bulge) 
and the formation of functional SGs (Nowak et al., 2008; Osorio et al., 2008; 
Snippert et al., 2010b).  
Although progress has been made during the past years in understanding 
mechanisms of HF morphogenesis, little is known about the process of SG 
development. 
 
4.1) Differences in HF morphogenesis in mouse back and tail skin 
 
HF morphogenesis is controlled by a network of signalling pathways (Duverger 
and Morasso, 2009; Fuchs, 2007). In back skin, molecular mechanisms 
regulating HF initiation have been well investigated during the past years (Fuchs, 
2007; Millar, 2002; Paus et al., 1999; Schmidt-Ullrich and Paus, 2005; Schneider 
et al., 2009). Although the main morphogenetic and structural properties seem to 
be similar for all HFs, patterning and spatio-temporal organisation differs 
between HFs of back and tail skin in mice. For instance, formation of back skin 
HFs starts with primary guard hairs at E14.5, whereas we detect first placodes of 
central HFs at E16.5 in mouse tail skin. It has been shown that back skin HFs 
develop in waves starting at the anterior part of the mouse body and proceeding 
towards the posterior end (Plikus et al., 2009; Plikus et al., 2008). Therefore, 
waves of signals inducing HF formation would attain tail skin with a delay 
compared to back skin resulting in the retardation of placode formation. 
Furthermore, in back skin, four different types of HFs develop in three distinct 
waves during skin morphogenesis (Duverger and Morasso, 2009; Schmidt-
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Ullrich and Paus, 2005). In contrast, our data demonstrate that tail skin HFs are 
formed in two waves generating one central and two outer HFs forming a unit 
(triplet). Another striking difference we have observed between back and tail skin 
was the arrangement of the different HF types within the skin. In back skin, 
zigzag and awl/auchene HFs are organised circularly around primary guard HFs 
(Duverger and Morasso, 2009). In tail skin, we observe HF triplets organised in 
rows from the anterior to the posterior end of the tail. 
This implies that different signals regulate the patterning in both regions of the 
body. It was proposed earlier by Turing (Turing, 1952) that a combination of 
activators and inhibitors regulates patterning in biological systems. For the skin, 
molecular mechanisms regulating the formation of the different types of back 
HFs have been well described. It was shown that Wnt and Dkk (a Wnt inhibitor) 
could be the activator-inhibitor pair regulating HF patterning in the skin (Sick et 
al., 2006). In addition, Ectodysplasin receptor (Edar) and BMP have been shown 
to control the initiation, the distribution and spacing at least of primary guard HFs 
in back skin (Mikkola, 2008; Mikkola and Thesleff, 2003; Mou et al., 2006). 
Secondary and tertiary HFs are induced by Noggin, a BMP-antagonist 
(Botchkarev et al., 2002). Furthermore, Lef1 signalling is required for formation of 
secondary HFs (Jamora et al., 2003). However, in these studies, the signalling 
pathways have not been analysed in tail skin. Therefore, it remains unclear, if 
distribution and spacing in tail skin is regulated by different signalling molecules 
than in back skin. Our data indicate that two types of HFs exist in tail skin. 
Central and side HFs are located in close proximity to each other and the space 
between two neighbouring triplets is very restricted. Therefore, signalling cues 
inducing the different types of HFs have to be directed very specifically.  
In the future, it will be important to analyse the distribution of potential activators 
and inhibitors as Wnt and Dkk or Edar and BMP in mouse tail skin. Additionally, 
it will be important to unravel the molecular signals governing formation of the 
different HF types in tail skin. This would provide further insight into the 
molecular mechanisms regulating HF spacing in this part of the body. Moreover, 
it would be interesting to analyse if two different types of HFs form the triplets in 
murine tail skin. Analysis of hair length and number of medulla columns in the 
hair hafts could be done to identify potential differences.  
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4.2) Formation of HF progenitor compartments 
 
During the past years, various stem and progenitor compartments within the HF 
have been identified (Blanpain and Fuchs, 2009; Jaks et al., 2010). However, it 
is not completely understood when these stem and progenitor compartments are 
generated and become first activated for tissue formation. First evidence for the 
formation of stem cell compartments during morphogenesis came from studies 
investigating the expression of the transcription factor Sox9. This molecule is a 
robust marker expressed in cells of the bulge region of HFs in adult mice (Nowak 
et al., 2008; Vidal et al., 2005). It was demonstrated that first Sox9 expressing 
cells could be detected during early HF morphogenesis. Moreover, epidermis 
specific depletion of Sox9 during embryogenesis resulted in a failure to form HF 
bulge stem cells and SGs (Nowak et al., 2008). Interestingly, Sox9 has been 
shown to be expressed by stem and progenitor cells of other tissues such as 
liver, pancreas, intestine and mammary epithelium (Furuyama et al., 2011; Guo 
et al., 2012; Kopp et al., 2011; van der Flier et al., 2009). These studies indicate 
that Sox9 is a general marker for stem cells in various tissues.  
The results presented in this work demonstrate that during early HF 
morphogenesis, the Sox9 positive cell population initially co expresses Lrig1, a 
marker for stem cells of the adult HF junctional zone (Jensen et al., 2009). We 
show that both markers are confined to distinct regions of the developing HF at 
later stages of HF morphogenesis. In particular, at stage 5 of HF morphogenesis, 
when SGs start to form, Sox9 expression is detected below the SG (Fig. 29). 
This indicates that Sox9 positive cells accumulate to form the stem cell 
compartment of the future bulge. In contrast, Lrig1 expression is located at the 
upper part of the HF surrounding the first established sebocytes. To date, it is not 
clear why Lrig1 and Sox9 are first co expressed by the same cells and define 
distinct stem cell compartments later in life. Reports about the expression of the 
stem cell marker Lgr6 showed that this marker is also expressed during early HF 
morphogenesis in a similar region as Sox9 and Lrig1 (Snippert et al., 2010b). 
Therefore, one can speculate that one general precursor population expressing 
multiple stem cell markers is initially established at the earliest stages of HF 
morphogenesis. With proceeding development marker expression becomes 
confined to distinct stem cell populations as these reach their final destination 
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within the HF. Until now, the cellular and molecular mechanisms regulating the 
separation of different stem cell compartments still need to be identified. It will be 
very interesting to address this further in the future.  
One possibility to determine if one of these marker positive stem cell pools is 
established first to give rise to the others could be to perform lineage tracing 
analysis. Using recently published Lrig1CreERT2-mice (Powell et al., 2012) 
could be useful to analyse if descendants of Lrig1 positive cells express Sox9 
and can be detected in the future bulge region. To analyse if Sox9 positive cells 
are the first stem cells to be established, lineage tracing with recently published 
Sox9CreER(T2) (Kopp et al., 2011) could be performed. Indeed, Sox9-Cre mice 
have already been used for lineage tracing during skin morphogenesis. Progeny 
of Sox9 expressing cells contributed to the entire HF, indicating that Lrig1 
positive cells potentially arose from Sox9 positive cells as well. However, co 
localisation of Lrig1 with descendants of Sox9 positive cells was not analysed in 
this study (Nowak et al., 2008). Another interesting point would be to analyse a 
potential functional interdependence of the Sox9 and Lrig1 stem cell 
compartments. Does the Sox9 positive stem cells population form in absence of 
Lrig1 and vice-versa? To address this, gene knockout studies could be combined 
with lineage tracing approaches applying the mouse models mentioned above.  
We have also analysed the localisation of the MTS24/Plet1 progenitor 
compartment. Previously, it had been demonstrated that bulge stem cell progeny 
transited various stem and progenitor compartments, including the MTS24/Plet1 
region of the HF before regenerating the SG (Petersson et al., 2011). 
MTS24/Plet1 positive cells are located in the upper isthmus of the adult HF and 
were highly clonogenic in vitro (Nijhof et al., 2006; Raymond et al., 2010). We 
wanted to address the question if progenitor cells positive for MTS24/Plet1 could 
be implicated in SG formation. Our analyses revealed that during HF 
morphogenesis, MTS24/Plet1 positive cells could only be detected at the upper 
part of the HF once a cluster of sebocytes was already established (Fig. 29). 
This indicates that the MTS24/Plet1 progenitor cell compartment is dispensable 
for the formation of the SG. However, later in life cells positive for MTS24/Plet1 
were suggested to be necessary to maintain proper SG regeneration (Nijhof et 
al., 2006). 
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Taken together, the results presented here demonstrate that distinct stem and 
progenitor cell compartments of mouse HFs are formed at different time points 
during HF morphogenesis. The localisation of the stem and progenitor cell 
compartments is highly dynamic at early stages of HF development. The scheme 
in Fig. 29 summarises our key findings with respect to the distribution of stem 
and progenitor cell compartments during HF morphogenesis.  
In the future, it will be important to elucidate the underlying molecular signals 
controlling the formation and localisation of different HF stem cell pools in more 
detail.  
 
 
Fig. 29) Progenitor cell dynamics during HF and SG morphogenesis. Sox9 (blue dots) and 
Lrig1 (red circles) positive stem cells co localise at the upper part of the HF (stage 2 and 3) 
before marker expression becomes confined to distinct compartments (stage 4 and 5). Sebocytes 
(magenta circles) arise among Lrig1 positive cells. MTS24/Plet1 positive cells are detected after 
SG development is initiated (yellow circles, stage 6). BrdU positive cells (green dots) are 
distributed all over the developing HF.  
 
4.3) Cellular and molecular mechanisms of SG morphogenesis 
 
The SG produces lipids and sebum and has crucial function in maintaining an 
intact epidermal barrier (Schneider and Paus, 2009; Thody and Shuster, 1989). 
Moreover, the SG is indispensable for the maintenance of the HF as it has been 
demonstrated that HFs are degraded in absence of functional SGs. In particular, 
hair loss due to destruction of the pilosebaceous unit (scarring alopecia) 
generally starts with SG ablation (Sundberg et al., 2000). In contrast, SGs exist 
without being attached to a HF. Meibomian glands in the eyelids or preputial 
gland secreting pheromones in rodents are only two examples (Schneider and 
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Paus, 2009). The existence of SGs without association to HFs is one aspect 
supporting the idea that the SG is evolutionarily older than the HF. It was 
hypothesised that SGs developed during evolution as vertebrates left the water 
to populate dry land. To protect the body against dehydration, glandular 
structures producing lipids were formed within the skin. The authors of this article 
propose that the HF developed later to efficiently drain the sebum produced by 
SGs to the surface of the skin (Stenn et al., 2008). These data and hypotheses 
again point out how crucial the SG is for the maintenance of the HF and the 
epidermal barrier. However, until now little was known about the formation of the 
SG during embryogenesis. It has been well described that the SG forms during 
HF morphogenesis at the upper part of the HF (Paus et al., 1999). First 
sebocytes of the future SG are detected at stage 5 of HF morphogenesis by 
OilRedO staining. Our data have shown that single sebocytes are also detected 
by staining for Scd1 or adipophilin, molecules associated with lipid metabolism. 
Scd1 is specifically expressed by sebocytes within the epidermis and is not only 
useful as a marker for early sebocytes. It has been shown that ablation of Scd1 
leads to SG hypoplasia (Binczek et al., 2007; Sampath et al., 2009). Moreover, 
Scd1 is the mutated gene in asebia-mice which are characterised by the 
absence of SGs due to a spontaneous mutation (Gates and Karasek, 1965; 
Zheng et al., 1999).  
Due to the specific expression of Scd1 in sebocytes, this marker could be used 
for genetic manipulation selectively in the SG. Reporter genes could be 
expressed specifically in the SG allowing isolation of SG cells at different time 
points. Subsequent transcriptional profiling could help to gain further insights into 
genes important for SG morphogenesis, differentiation and maintenance. 
Moreover, gene expression could be manipulated in cells of the SG. To do so, 
inducible Cre recombinase in combination with EGFP (EGFP-IRES-CreERT2, 
(Barker et al., 2007)) could be expressed under control of the Scd1 promoter, 
enabling knock out of genes specifically within the SG. Furthermore, by using 
this construct, Scd1 positive cells would be marked by the expression of EGFP. 
Due to the early expression of Scd1 during SG morphogenesis, we would be 
able to isolate first sebocytes by FAC sorting. However, one would expect a low 
number of positive cells at early stages of SG morphogenesis. To overcome the 
challenge of isolating RNA from low amounts of cells, the single-cell cDNA library 
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approach applied in this thesis could be used (Hartmann and Klein, 2006). Thus, 
analysis of gene expression profiles of isolated sebocytes would be possible. 
 
To date, molecular mechanisms regulating SG morphogenesis are poorly 
investigated. However, several signalling pathways including Hh and Wnt have 
been shown to be involved in differentiation and maintenance of the SG. It has 
been demonstrated that repression of Lef1 / β-Catenin signalling by expression 
of a truncated Lef1-transcription factor lacking the β-Catenin binding site leads to 
increased sebocyte differentiation (Niemann et al., 2002). This indicates that 
repression of Lef1 / β-Catenin signalling might be necessary for the formation of 
first sebocytes during morphogenesis. Moreover, Hh signalling influences SG 
development. Increased Hh signalling resulted in formation of increased size and 
number of SGs. In contrast, when Hh signalling was inhibited during skin 
morphogenesis, SGs failed to form (Allen et al., 2003; Gu and Coulombe, 2008). 
In addition, PPARγ could play a role in the formation of sebocytes. PPARγ-
knockout mice die during embryogenesis. However, the influence of PPARγ in 
postnatal skin was analysed in chimeras of wt and PPARγ-null cells. These 
studies suggested that PPARγ plays a role in sebocyte differentiation as SGs 
formed in the chimeras were generated by wt cells (Rosen et al., 1999). This is 
supported by a study demonstrating that PPARγ ligands promote sebocyte 
differentiation in vitro (Rosenfield et al., 2000).  
In the future, molecular mechanisms regulating early SG morphogenesis need to 
be further elucidated.  
 
4.3.1) A cluster of sebocytes generates two SGs in mouse tail skin 
 
Interestingly, our data showed that the two SGs attached to one HF in mouse tail 
skin arise from one cluster of sebocytes. To date, it is not clear which signals 
control the partitioning of the two clusters. Certainly, the tension force produced 
by the developing hair shaft cannot be the only reason, since other HFs also 
produce the hair shaft but contain only one SG.  
We usually observed that the cluster of sebocytes divided into two at stage 6 or 7 
of HF morphogenesis. At this stage of development, the cluster of sebocytes 
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may have attained a critical size triggering the segregation into two clusters. One 
could hypothesise that the SGs of HFs harbouring only one glandular structure 
never reach this critical size and therefore, only one SG is formed. This 
interesting questions certainly needs further investigation in the future.  
Another possibility could be that branching morphogenesis is involved in splitting 
up the initial sebocyte cluster into two portions. So far, nothing has been reported 
about the involvement of branching mechanisms in SG development. However, 
in other epithelial appendages and organs such as the mammary gland, the 
salivary gland or the lung, branching is an important step during morphogenesis 
(Affolter et al., 2003). One candidate proposed to be involved in regulating 
branching in the lung or the salivary gland is Sonic Hedgehog (Shh) (Jaskoll et 
al., 2004; Pepicelli et al., 1998). Interestingly, Hedgehog (Hh) signalling also 
plays an important role in regulating the development of the SG (Gu and 
Coulombe, 2008). It was shown that inhibition of Hh signalling blocks SG 
development, whereas activation of the pathway leads to an increase in size and 
number of SGs (Allen et al., 2003). This is particularly interesting as one could 
hypothesise that increased Hh signalling leads to increased branching during the 
development of the SG. This could lead to the higher number of SGs observed in 
mutant mice displaying aberrantly activated Hh signalling (Allen et al., 2003). 
Besides Hh signalling, other molecules like Fibroblast Growth Factor 10 (FGF10) 
are suggested to be involved in regulating branching of epithelial appendages 
(Lu et al., 2006; Mailleux et al., 2002). FGF10 was also shown to be important for 
proper HF development (Petiot et al., 2003). However, much less is known about 
the influence of FGF10 on the development of the SG.  
Taken together, our data more likely support that partitioning of the sebocyte 
cluster into two occurs to a due to mechanism other than branching 
morphogenesis. The images shown in this thesis rather suggest segregation of 
the cluster than forming a new branch. However, the mechanism controlling the 
partitioning of the sebocyte cluster remains unknown. Due to the fact that some 
HFs contain one SG whereas others harbour two, one can speculate that 
different signalling pathways regulate SG segregation at different types of HFs. 
Therefore, it will be very interesting in the future to analyse the underlying 
mechanisms regulating the formation of one or two SGs.  
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4.3.2) Lrig1 positive stem cells generate sebocytes 
 
Our results clearly suggest that sebocytes are generated by Lrig1 positive stem 
cells at stage 5 of HF morphogenesis. Lrig1 positive cells proliferate, whereas 
Scd1 positive sebocytes did not incorporate BrdU or EdU labels upon short term 
labelling experiments, indicating that sebocytes do not divide. However, pulse-
chase experiments applying EdU showed a dilution of the EdU label from Lrig1 
positive cells towards Scd1 expressing sebocytes. Analyses of spindle pole 
orientation in the Lrig1 stem cell compartment provided evidence that 
asymmetric cell fate decision of Lrig1 positive cells leads to the formation of cells 
able to differentiate towards the sebocyte lineage. Our data shows that a majority 
of cell divisions in the upper part of the HF occurred perpendicularly to the 
basement membrane. This indicates that Lrig1 expression marks precursor cells 
for sebocytes during epidermal morphogenesis. Cell type specification towards 
the sebocyte lineage can occur after one cell division of Lrig1 positive cells, 
demonstrated by the EdU-experiment. To a lesser extent, Lrig1 positive cells 
divided in parallel to the basement indicating an expansion of the stem cell 
compartment. Thus, the Lrig1 positive stem cells compartment can be 
maintained. Moreover, one could hypothesise that Lrig1 positive cells can also 
provide cells for the elongating HF. A similar expression pattern was described 
during anagen phase of the hair cycle, where Lrig1 expression could be detected 
below the SG extending towards the bulge region (Jensen et al., 2009).  
To further strengthen the data demonstrated here, lineage tracing experiments 
could be conducted. Crossing recently generated Lrig1CreERT2 (Powell et al., 
2012) mice with Cre-sensitive reporter mice and activating Cre during SG 
morphogenesis could provide further insight into the role of Lrig1 positive stem 
cells in the formation of the SG and the HF. This approach would be useful to 
directly show that Lrig1 positive stem cells give rise to sebocytes.  
Although Lrig1 positive stem cells play a crucial role in the formation of the SG, 
Lrig1 itself does not seem to have a functional role for SG formation and 
homeostasis. Lrig1 knockout mice show epidermal hyper proliferation, but no 
effects on the SG have been reported (Jensen et al., 2009; Suzuki et al., 2002). 
However, in other epithelial systems such as the intestine, Lrig1 also seems to 
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have functional relevance. Recently, it was described that Lrig1 is highly 
expressed in intestinal stem cells and controls proliferation. Knockout of Lrig1 
leads to a dramatic increase of proliferation in intestinal stem cells (Wong et al., 
2012). Thus, Lrig1 appears to be a more general marker for stem cells of 
different tissues.  
 
4.4) Origin of cells forming HF and SG 
 
It has been demonstrated that the HF stem cell population expressing the 
transcription factor Sox9 is formed during embryonic development of the skin. 
These stem cells were able to form HFs and give rise to SGs during 
morphogenesis. Ablation of Sox9 in embryonic skin lead to a failure in formation 
of the HF bulge region. Moreover, SGs were not detected in mice lacking Sox9 
expression (Nowak et al., 2008).  
To identify the origin of cells forming the SGs during embryogenesis and early 
postnatal development, we have performed lineage tracing experiments applying 
a mouse model recently established in our laboratory. This model 
(AK15CreER(G)T2/R26REYFP) allows to label individual stem cells in the bulge 
region of adult HFs. The fate of K15 positive stem cells could be traced within the 
HF. Interestingly, K15 derived progeny was able to regenerate the SG 
(Petersson et al., 2011). In addition, expression of K15 protein could already be 
detected during embryogenesis at E15.5 in the IFE (Nöbel, 2009). Therefore, we 
used AK15CreER(G)T2/R26REYFP mice to perform lineage tracing experiments 
during HF and SG morphogenesis. The data provided here show that the K15 
promoter driving inducible Cre indeed was already active at E15.5 in cells of the 
epidermis. This allowed to use AK15CreER(G)T2/R26REYFP mice to perform 
lineage tracing during HF morphogenesis, labelling cells in the IFE and tracing 
their fate during formation of HFs and SGs.  
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4.4.1) Specific targeting of individual IFE cells during skin 
morphogenesis 
 
In a first set of experiments, we have analysed the timing of Cre recombinase 
activation when labelling was performed during embryogenesis. We have 
injected Tam at E16.5 and analysed for Cre recombinase via YFP expression 
one or two days later. Our results show that activation of Cre recombinase during 
embryogenesis (E16.5) lead to specific labelling of individual cells in the 
epidermis of AK15CreER(G)T2/R26REYFP mice detectable at E18.5. 
Importantly, cells constituting the already established placodes were not labelled 
within the first days following Cre activation. Thus, we could conclude that all 
labelled progeny of K15 positive cells is derived from the IFE. With further 
tracing, clusters of labelled cells were detected in the IFE indicating expansion of 
K15 positive cells. Infrequently, also individual YFP positive cells were detected 
several days after Cre activation in the IFE. This could indicate that these cells 
are more quiescent and have not divided yet.  
To further improve our lineage tracing approach in the future, it will be important 
to analyse K15 promoter activity during skin morphogenesis in more detail and to 
optimise the experimental design for Cre recombinase activation. To date, it is 
only known, that K15 protein is detectable from E15.5 onwards, indicating that 
the promoter is active slightly before (Nöbel, 2009). To clearly state activity of the 
K15 promoter, in situ hybridisation of K15 mRNA needs to be conducted. 
Furthermore, qRT-PCR of skin samples isolated at embryonic stages could also 
reveal the time frame of K15 promoter activation.  
Moreover, molecular characterisation of early labelled K15 positive cells is 
required to identify if similarities in gene expression profiles with K15 positive 
cells from the adult HF bulge region can be detected. This would answer the 
question if K15 positive cells constitute a type of epidermal progenitor cells.  
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4.4.2) Progeny of K15 positive IFE cells contribute to HF and SG 
morphogenesis 
 
To analyse the fate of K15 positive cells labelled in the IFE, we have traced 
progeny of these cells till postnatal time points during HF and SG development. 
Interestingly, our lineage tracing experiments suggested that cells originating in 
the IFE are contributing to both, SG and HF formation. First, initially labelled cells 
expanded to form clusters in the IFE. Subsequently, clonogenic expansion of 
labelled cells from IFE towards the SG or further down the HF was detected. To 
quantify the localisation of labelled cells at later tracing time points, we have 
classified the labelling pattern describing the regions within the pilosebaceous 
units containing YFP positive cells. Our initial quantification revealed that the 
majority of primary HFs analysed, contained labelled cells only in the upper part 
of the HF and not below the SG. However, distribution of YFP positive cells in 
secondary HFs was less clear. Most of the analysed secondary HFs had 
reached only stage 2 or 3 of HF morphogenesis. Here, we detected labelled cells 
randomly distributed within the developing HFs and it was not possible to 
distinguish between different regions of the HF. One possible explanation for this 
random labelling pattern could be the different time point of Cre-activation 
compared to the primary HF. Potentially, the mechanism of HF and SG formation 
differs between primary and secondary HFs. To investigate this in more detail, 
more mice will be analysed in the future. In addition, labelling at later time points 
during morphogenesis will to be performed. In the future, we plan to perform co 
immunofluorescence studies to better distinguish between different regions 
within the HF. Additionally, we also observed HFs with labelled cells located 
below the SG. Certainly, K15 derived progeny contributed here to the formation 
of the hair shaft, the IRS or the ORS.  
To investigate the ultimate fate of progeny derived from K15 positive cells of the 
IFE, we have also analysed later time points of tracing. Importantly, the majority 
of labelled P15 HFs (induced at E16.5) contain YFP positive cells in the 
infundibulum or the SG but not below these compartments. Interestingly, this 
pattern was also observed in secondary HFs, where initially labelled cells could 
not be attributed to a distinct region of the developing HF. This suggests that 
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cells derived from the IFE are recruited to the infundibulum and or subsequently 
to the SG and contribute to HFs more rarely. 
However, at P15 we also detected HFs containing labelled cells in the SG and in 
the HF. Moreover, HFs with labelled cells only below the SG were observed. 
These data propose that progeny of K15 positive cell in the IFE are able to form 
HFs and SGs. Our data obtained so far suggest that contribution to SGs occurs 
more frequently than involvement in HF formation. However, we cannot rule out 
that YFP positive cells in the SGs at P15 are derived from K15 progeny that first 
populated the HF bulge region and later contributed to SG (re)generation.  
Taken together, our initial data suggest that mostly, K15 derived progeny 
contribute to the upper part of the HF, the infundibulum or the SG. To a lesser 
extent, cells localise to the HF and are detected in the bulge region when HFs 
are in the first resting phase of the hair cycle. In order to evaluate the data 
statistically, more mice are currently analysed. However, these initial results 
suggest that K15 positive cells in the IFE constitute a population of stem or 
progenitor cells able to give rise to all lineages of the epidermis. In contrast to 
Sox9 positive cells that localise to placodes and gave rise to cells of HFs and 
SG, K15 positive cells are derived from the IFE. When IFE cells were labelled at 
E17, when HGs (stage 2) of primary HFs are already established, progeny of 
K15 positive cells also contributed to HFs and SGs. This suggests that the 
recruitment of cells from the IFE seems to be a permanent process during HF 
and SG development. The data that we show here provide novel insights into the 
process of HF and SG development.  
Recently, reporter mice allowing multiple colour lineage tracing have been 
described. Stochastically, one out of four fluorescent proteins is expressed in 
cells with active Cre recombinase (R26R-Confetti, (Snippert et al., 2010a)). 
These mice allow distinguishing between progeny of different stem cells of the 
same niche. By crossing these mice with our AK15CreER(G)T2-mice we would 
be able to trace different stem cells to their eventual fate. One can imagine that 
different stem cells, marked by different fluorescent proteins, contribute to the HF 
or the SG. More precisely, one would be able to discriminate if labelled cells in 
the SG and the bulge region of one HF are derived from the same “cell of origin”. 
This would help understanding the process of the formation of HFs and SGs by 
cells originating in the IFE.  
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4.4.3) Test for proliferative capacity of K15 derived progeny 
 
We have analysed proliferative capacity of K15 derived YFP positive progeny by 
performing colony forming assays. Our initial results indicate that YFP positive 
cells isolated from newborn AK15CreER(G)T2/YFP+/+ mice formed a higher 
number of colonies in vitro than YFP negative cells. This indicates that K15 
derived progeny have a higher self renewing potential. However, these initial 
experiments need to be repeated.  
Assuming that K15 derived progeny have stem or progenitor cell properties, we 
expect YFP positive cells to form more colonies larger than 2mm2 (representing 
holoclones) compared to YFP negative cells. To address if K15 derived progeny 
have the capacity to generate all lineages of the skin, transplantation assays 
could be performed. Following Cre activation in K15 positive cells, YFP positive 
and negative cells would be isolated via FAC sorting. Subsequently, epidermal 
cells would be mixed with primary dermal fibroblast and transplanted onto the 
back of Nude mice in silicone chambers (Fusenig et al., 1983; Weinberg et al., 
1993). Grafts would be monitored for several weeks to analyse potential hair 
growth. It will be important to compare the regenerative potential of YFP positive 
and negative epidermal cells.  
 
4.5) Role of Rac1 in tumour formation 
 
Rac1 was previously shown to be important for the maintenance of the adult HF 
stem cell region. In absence of Rac1, the cycling part of the HF could not be 
maintained resulting in a progressive hair loss (Chrostek et al., 2006). In a similar 
study, it was demonstrated that in absence of Rac1, HFs morphogenesis was 
impaired and HFs never formed properly. Moreover, grafted Rac1 deficient 
keratinocytes were not able to reconstitute HFs and SGs although formation of 
the IFE was not impaired (Castilho et al., 2007). In contrast, activation of Rac1 
lead to an expansion of keratinocytes capable of clonal growth (Benitah et al., 
2005). Altogether, these studies indicate that Rac1 has crucial function in 
regulating stem cell behaviour.  
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In addition, over expression of the small GTPase Rac1 has been implicated in 
the progression of several tumours such as breast, testicular or gastric cancer 
(Gomez del Pulgar et al., 2005; Kamai et al., 2004; Pan et al., 2004; Schnelzer et 
al., 2000). Moreover, it was reported that depletion of Rac1 in epidermal cells 
prevented mice from DMBA/TPA induced skin tumour formation (Wang et al., 
2010). These reports propose an important role for Rac1 in tumour formation and 
progression. However, the role of Rac1 in skin tumours was insufficiently 
addressed.  
We have analysed the effect of activated Rac1 (L61Rac1) in benign skin 
tumours. Therefore, K14ΔNLef1/L61Rac1 mice were generated. In a one step 
carcinogenesis experiment, K14ΔNLef1/L61Rac1 mice did not develop 
significantly more tumours than K14ΔNLef1 control mice. This indicates that 
active Rac1 does not regulate frequency of tumour formation.  
Supporting the data mentioned above about Rac1 function in HF stem cells, we 
found increased expression of Lrig1 and MTS24/Plet1 in K14ΔNLef1/L61Rac1 
sebeoma and carcinoma compared to K14ΔNLef1/L61Rac1 adenoma and 
K14ΔNLef1 adenoma (Sharma, 2011). 
 
4.5.1) Activation of Rac1 leads to decreased sebocyte differentiation 
in skin tumours 
 
Interestingly, in addition to adenomas and sebeomas K14ΔNLef1/L61Rac1 mice 
developed undifferentiated tumours (carcinomas). K14ΔNLef1/L61Rac1 
adenomas resembled K14ΔNLef1 adenomas. Undifferentiated, proliferative 
basal cells at the periphery of the adenoma lobules surrounded mature, Scd1 
positive sebocytes in the centre. Distribution and amount of sebocytes were 
comparable between the adenomas of these two mouse strains. 
K14ΔNLef1/L61Rac1 sebeomas showed less expression of the sebocyte 
differentiation marker Scd1 on transcriptional and on protein level. A further 
decrease in Scd1 expression was observed in K14ΔNLef1/L61Rac1 carcinomas. 
Similar results were obtained for expression of adipophilin, another sebocyte 
differentiation marker (Ostler et al., 2010; Sharma, 2011). The gradual decrease 
of Scd1 was accompanied by an increase in BrdU positive cells. In both, 
K14ΔNLef1/L61Rac1 and K14ΔNLef1 adenomas, BrdU positive cells were 
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confined to the outer layer of undifferentiated cells at the periphery of the tumour 
lobules that are filled with differentiated sebocytes. In K14ΔNLef1/L61Rac1 
sebeomas, BrdU positive cells were observed slightly more randomly distributed 
within the tumour tissue. This effect was even stronger in K14ΔNLef1/L61Rac1 
carcinomas, where BrdU positive cells were distributed all over the tumour mass.  
Our data indicate that active Rac1 leads to a decrease in differentiation in 
sebaceous tumours. More undifferentiated, proliferative cells are detected. To 
date, the role of Rac1 in regulating differentiation is not well investigated. 
However, it has been suggested that active Rac1 inhibits differentiation of 
muscle cells in vitro (Heller et al., 2001). Also, it was proposed by analysing 
samples of human urinary cancer that high Rac1 activity was associated with low 
grades of differentiation (Kamai et al., 2010). Interestingly, Rac1 has been 
implicated in regulating the cell cycle (Coleman et al., 2004). Activation of Rac1 
was associated with stimulation of cell cycle progression (Olson et al., 1995). 
Furthermore, it was reported that Rac1 can promote G1-S transition in the cell 
cycle by increasing CyclinD1 (Klein et al., 2007). In line with that, we have 
detected elevated proliferation in K14ΔNLef1/L61Rac1 tumours. However, the 
mechanism through which active Rac1 stimulates cell cycle progression and 
proliferation are still largely unknown.  
 
4.5.2) Gene expression profile is altered in cells of 
K14ΔNLef1/L61Rac1 carcinomas 
 
In order to dissect the molecular mechanisms underlying the altered histology of 
the K14ΔNLef1/L61Rac1 carcinomas compared to K14ΔNLef1/L61Rac1 
adenomas, micro array analyses were performed. We have compared 
expression profiles of basal cells and sebocytes isolated from 
K14ΔNLef1/L61Rac1 adenomas with expression profiles of undifferentiated cells 
from K14ΔNLef1/L61Rac1 carcinomas. Our results show significant alterations in 
gene expression between cells from K14ΔNLef1/L61Rac1 adenomas and 
carcinomas. Among the regulated candidates, we found members of the lipid 
metabolism such as Scd1 or adipophilin, up regulated in sebocytes of 
K14ΔNLef1/L61Rac1 adenomas compared to undifferentiated cells from 
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K14ΔNLef1/L61Rac1 carcinomas. This supported the data we have obtained in 
immunofluorescence analysis before ((Sharma, 2011) and this work).  
Moreover, three members of the Elovl-family, namely Elovl3, 4 and 6 were up 
regulated in sebocytes of K14ΔNLef1/L61Rac1 adenomas. Elovl3 and 4 have 
been previously associated with lipid metabolism of sebocytes and maintenance 
of an intact epidermal barrier function (Cameron et al., 2007; Li et al., 2007; 
Westerberg et al., 2004). Interestingly, our qRT-PCR results showed that these 
genes of the lipid metabolism were already expressed in the basal cells of 
K14ΔNLef1/L61Rac1 adenomas. Basal cells at the periphery of the sebocyte 
lobules within adenomas are proliferative and undifferentiated. They give rise to 
maturating sebocytes. Our data indicate that these cells might already be 
committed to their ultimate sebocyte cell fate. The fact that the expression of 
genes associated with lipid metabolism was down regulated in the cells isolated 
from K14ΔNLef1/L61Rac1carcinoma indicates that these cells had lost the ability 
to differentiate towards the sebocyte lineage.  
Another interesting candidate gene, differentially regulated among sebocytes of 
K14ΔNLef1/L61Rac1 adenoma and undifferentiated cells of 
K14ΔNLef1/L61Rac1 carcinomas was Dhcr24. Dhcr24 is an enzyme converting 
desmosterol to cholesterol. It has been demonstrated that knock out of Dhcr24 in 
mice leads to severe skin barrier defects in mice (Mirza et al., 2009; Mirza et al., 
2008; Mirza et al., 2006). We found Dhcr24 up regulated in sebocytes and basal 
cells of K14ΔNLef1/L61Rac1 adenoma compared to K14ΔNLef1/L61Rac1 
carcinoma. This was particularly interesting because Dhcr24 had been shown to 
be over expressed at early stages of prostate cancer but was down regulated in 
more progressed stages and metastasis of this cancer type (Battista et al., 
2010). This correlates with our data if we assume that K14ΔNLef1/L61Rac1 
sebeoma and carcinoma are progressive stages of K14ΔNLef1/L61Rac1 
adenoma. One could speculate that carcinomas develop from adenomas due to 
down regulated Dhcr24 expression. Moreover it would be utile to use Dhcr24 as 
a marker for progression of sebaceous adenomas towards sebaceous 
carcinomas. Interestingly, our data demonstrate that expression of Dhcr24 
protein was significantly decreased in K14ΔNLef1/L61Rac1 tumours compared 
to K14ΔNLef1 adenoma. A similar regulation was also observed on 
transcriptional level when analysing RNA from whole tumour lysates (Sharma, 
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2011). As Dhcr24 expression is lower in K14ΔNLef1 adenoma compared to 
K14ΔNLef1/L61Rac1 adenoma (Sharma, 2011), it is tempting to speculate that 
Dhcr24 expression might be regulated via active Rac1.  
Besides genes involved in lipid metabolism, some cell cycle associated genes 
e.g. Gankyrin were up regulated in undifferentiated cells from 
K14ΔNLef1/L61Rac1 carcinomas compared to sebocytes and basal cells from 
K14ΔNLef1/L61Rac1 adenomas. Gankyrin was shown to be up regulated in 
oesophageal squamous cell carcinoma (Ortiz et al., 2008) and has anti apoptotic 
effects. More recently, it was proposed that levels of Gankyrin were closely 
associated with dedifferentiation of tumours in hepatoma patients (Sun et al., 
2011). These studies together with our result render Gankyrin an interesting 
candidate for further analysis. 
Furthermore, we identified Prominin2 (Prom2) to be regulated among the 
different tumour cell populations. Prom2 is a glycoprotein expressed in epithelial 
cells (Florek et al., 2007) and was up regulated in undifferentiated cells of 
K14ΔNLef1/L61Rac1 carcinoma to basal cells from K14ΔNLef1/L61Rac1 
adenoma. Prom2 is highly similar to Prominin1, established as surface marker of 
renal or prostatic epithelial stem cells (Bussolati et al., 2005; Fargeas et al., 
2003; Richardson et al., 2004). This provokes the question, if Prom2 could also 
be a useful marker for cells with stem cell characteristics in the skin or in skin 
tumours. Up regulated Prom2 in cells from K14ΔNLef1/L61Rac1 carcinoma 
could indicate that these cells might be stem or progenitor cells. Analysing the 
expressing of Prom2 in skin and tumour samples and performing clonogenicity 
assays with tumour-cells will help to evaluate its utility as a potential stem-cell 
marker.  
Interestingly, no significantly regulated genes were found when comparing the 
profiles of basal cells and differentiated sebocytes both isolated from 
K14ΔNLef1/L61Rac1 adenoma. This indicates that genes needed for the 
function of differentiated sebocytes are already expressed in earlier stages of 
differentiation. Therefore, expression profiles of basal cells and sebocytes from 
K14ΔNLef1/L61Rac1 adenoma showed strong overlap. Another potential 
explanation could be the limitations of the cell isolation method. Basal cells are 
localised in close proximity to sebocytes in K14ΔNLef1/L61Rac1 adenoma. 
Therefore, it is possible that during laser micro dissection of basal cells, parts of 
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sebocytes were also catapulted into the collection tube. This would explain why 
not significant differences in gene expression were detected between sebocytes 
and basal cells. 
To gain insights into genes which are regulated by Rac1 signalling, we will 
proceed to analyse these initial data using real-time PCR. Comparing the 
expression profile of cells isolated from K14ΔNLef1/L61Rac1 tumours with 
profiles of cells from K14ΔNLef1 adenomas could help to identify genes that are 
specifically regulated by activated Rac1.  
Taken together, the data obtained from oligo nucleotide arrays revealed 
interesting candidate genes regulated in cells of differentiated and 
undifferentiated sebaceous tumours in K14ΔNLef1/L61Rac1 mice. Further 
investigation will potentially lead to the identification of novel target genes for 
skin tumour therapy.  
 
4.6) Perspectives 
 
The data presented here provide novel insights into the establishment of stem 
and progenitor cell compartments during skin morphogenesis. We propose the 
existence of a common progenitor population giving rise to HF stem cells and 
SGs. The principle of a common progenitor cell population could apply to the 
development of other organs and tissues as well, especially because the 
analysed markers are also expressed in other tissues.  
Our data from the lineage tracing approach suggest that SGs are directly formed 
by cells of the IFE. For the future, it will be interesting to investigate whether HFs 
and SGs are formed by the same stem cells. Alternatively, stem cells could 
already be primed for different cell fates during early morphogenesis of the 
pilosebaceous unit. By using a multi colour lineage tracing approach one could 
distinguish between the progeny of individually labelled different stem cells and 
track their fate during HF and SG morphogenesis  
Our results identifying the cellular processes and progenitor compartments 
involved in SG development could be of major importance for skin tumour 
biology as it was proposed that during tumour formation, basic steps of 
morphogenesis are recapitulated. Understanding the dynamics of stem cell 
                                                                                                         Discussion 
99 
behaviour during skin development will help to unravel cellular processes of early 
tumour formation and might have relevant diagnostic and therapeutic value. 
Furthermore, the lineage tracing approach together with the identification of 
different stem and progenitor compartments demonstrate that mouse tail skin 
constitutes an excellent model system to study important general processes 
such as cell type specification and stem cell function in a three dimensional 
fashion  
In addition, we provide new insights into the role of Rac1 in skin tumour 
formation. In a sebaceous tumour model, activated Rac1 leads to the formation 
of undifferentiated tumours, accompanied by a decrease in sebaceous 
differentiation. This is reflected by a change in gene expression. Genes 
implicated in lipid metabolism are down regulated in undifferentiated tumour 
cells. Moreover we have identified progenitor markers and cell cycle regulators. 
Further analysis of these candidates could lead to the identification of novel 
target genes for therapy of skin tumours.  
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5) Summary 
 
Hair follicles (HFs) and sebaceous glands (SGs) constitute the two essential 
parts of the pilosebaceous unit in mammalian skin, substantially contributing to 
the formation of an intact epidermal barrier. Over the past decades, considerable 
progress has been made in understanding the cellular and molecular 
mechanisms of HF formation and various stem cell (SC) and progenitor 
compartments have been described within the HF. Although promising initial 
studies exist, the formation of the diverse HF SC and progenitor compartments 
during morphogenesis still remains to be elucidated. In particular, cellular 
mechanisms of SG morphogenesis occurring in close association with HF 
development are not well understood. 
Here, we investigate the spatio-temporal organisation of HF SC and progenitor 
compartments during HF and SG morphogenesis. HF SC compartments of the 
future bulge region (Sox9 positive) and the junctional zone of the upper adult HF 
(Lrig1 positive) are detectable prior SG formation. Our studies reveal that Sox9 
and Lrig1 are initially co expressed by cells of the HF. Once the SG starts to 
form, expression of each marker is localised to distinct cell compartments. 
Importantly, Lrig1 positive SCs at the upper part of the HF proliferate and give 
rise to sebocytes by asymmetric cell fate decision. Sox9 positive SCs localise to 
the future bulge region. In contrast, progenitor cells of the HF isthmus region, 
expressing MTS24/Plet1 were not detected before SG formation was initiated 
indicating that these cells are dispensable for SG development.  
To decipher the origin of cells forming the SG, lineage tracing of basal 
keratinocytes was performed during HF and SG morphogenesis. Importantly, our 
data suggest that progeny of multipotent cells labelled in the IFE during 
embryogenesis can contribute to SG formation independently of HF 
development. 
Previously, it has been shown that the small GTPase Rac1 is crucial for 
maintaining the SC compartment of the HF. Therefore, we have addressed the 
role of activated Rac1 in tumour formation, differentiation and progression. 
Interestingly, in addition to sebaceous adenomas, less differentiated tumours 
(“carcinomas”) were formed upon expression of active Rac1 in mouse epidermis. 
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Expression of HF SC and progenitor markers was increased at the expense of 
sebocyte differentiation in these tumours. To identify differentially regulated 
genes in the carcinomas, we have compared sebocytes and basal cells from 
adenomas with undifferentiated cells from carcinomas. Genes down regulated in 
carcinoma cells mainly comprise candidates involved in lipid metabolism 
associated with sebocytes. Interestingly, regulated genes also involve 
candidates regulating the cell cycle or previously implicated in tumour formation 
in other tissues. 
These results suggest that activated Rac1 in sebaceous adenomas influences 
differentiation and proliferation leading to more progressive tumours.  
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6) Zusammenfassung 
 
Haarfollikel (HF) und assoziierte Talgdrüsen (TD) tragen maßgeblich zur 
Entstehung und Erhaltung der Hautbarriere bei. Zelluläre und molekulare 
Mechanismen, die an der Entstehung des HFs beteiligt sind, wurden in den 
letzten Jahren gut charakterisiert und diverse Stammzell (SZ)- und 
Progenitorpopulationen wurden im HF beschrieben. Erste Untersuchungen 
zeigen, dass einzelne SZ Marker bereits in der frühen HF-Morphogenese 
detektiert werden. Bisher ist jedoch noch nicht ausreichend verstanden, wann 
die verschiedenen SZ- und Progenitorpopulationen des HFs entstehen und ob 
sie maßgeblich an der Morphogenese von HF und TD beteiligt sind.  
Im Rahmen dieser Arbeit wurde die zeitliche und räumliche Anordnung von SZ- 
und Progenitorpopulationen während der HF-Morphogenese analysiert. Die SZ-
Kompartimente der späteren „bulge“-Region (Sox9 positiv) und der „junctional“ 
Region des oberen adulten HFs (Lrig1 positiv) entstehen noch vor der 
Entwicklung der TD. Unsere Daten zeigen, dass Sox9 und Lrig1 zunächst 
gleichzeitig von Zellen des HFs exprimiert werden. Sobald erste Zellen der TD 
erkennbar waren, wurde Lrig1 Expression im oberen Teil des HFs um die ersten 
Sebozyten detektiert. Außerdem wurde gezeigt, dass bei der Teilung von Lrig1-
positiven SZ durch asymmetrische Zelldeterminierung Sebozyten gebildet 
werden. Sox9-exprimierende SZ hingegen wurden unterhalb der entstehenden 
TD, in der zukünftigen HF-„bulge“ detektiert. Im Gegensatz zu den Lrig1- und 
Sox9-exprimierenden SZ-Populationen wurde die MTS24/Plet1 positive 
Progenitorpopulation der Isthmus-Region des HFs erst detektiert, nachdem 
bereits Sebozyten erkennbar waren.  
Um den Ursprung der Zellen, die die TD bilden zu identifizieren, wurden 
„lineage“ Analysen während der frühen Hautmorphogenese durchgeführt. 
Interessanterweise konnten die Abkömmlinge von basalen Zellen der IFE nicht 
nur in die SZ Region des adulten HFs, sondern unabhängig davon, auch in die 
TD verfolgt werden. 
In vorangegangenen Studien wurde gezeigt, dass die kleine GTPase Rac1 eine 
wichtige Rolle in der Erhaltung des HF SZ Kompartiments spielt. Um nun die 
Rolle von Rac1 in der Entstehung, Differenzierung und Progression von 
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Hauttumoren zu untersuchen, wurde konstitutiv aktives Rac1 in gutartig 
differenzierten TD-Tumoren exprimiert. Interessanterweise entstanden neben 
gutartigen TD-Adenomen auch weniger differenzierte Karzinome. Die Expression 
von HF SZ Markern war in diesen undifferenzierten Karzinomen erhöht, 
wohingegen Sebozytendifferenzierung unterdrückt war. Um Änderungen der 
Genexpression in Karzinomen festzustellen und die Auswirkungen der 
Aktivierung von Rac1 zu untersuchen, wurden Genexpressionsprofile von 
Sebozten und Basalzellen aus Adenomen mit undifferenzierten Zellen aus 
Karzinomen verglichen. In Karzinomzellen waren vor allem Gene des mit 
Sebozytendifferenzierung assoziierten Lipidmetabolismus herunter reguliert. 
Zusätzlich konnten wir auch Gene identifizieren, die der Zellzyklusregulation eine 
Rolle spielen oder bereits mit der Tumorentstehung in anderen Geweben in 
Verbindung gebracht wurden. Diese Ergebnisse zeigen, dass konstitutiv aktives 
Rac1 in TD-Tumoren die Differenzierung und Proliferation beeinflusst und zur 
Bildung von progressiveren Tumoren führt. 
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10) List of abbreviations 
 
APC adenomatous polyposis coli 
AP alkaline phosphatase 
BCIP 5-Bromo-4-chloro-3-indolyl phosphate 
BMP bone morphogenetic protein 
BrdU 5-bromo-2‘-deoxyuridine 
cDNA complementary desoxyribonucleic acid 
CFE Colony forming efficiency 
CK1-α casein kinase 1alpha 
DAPI 4′,6-Diamidin-2-phenylindol 
DEPC Diethylpyrocarbonate 
dH2O distilled water 
Dhcr24 24-Dehydrocholesterol reductase (Seladin1) 
DMBA 7,12-Dimethylbenz(a)anthracene 
DP dermal papillae 
DTT Dithiothreitol 
E embryonic day 
EDTA Ethylenediaminetetraacetic acid 
EdU 5-Ethynyl-2´-deoxyuridine 
EGF epiderma growth factor 
Elovl 3 (4, 6) Elongation of very long fatty acids like 3 (4, 6) 
ER Oestrogen receptor 
EtOH Ethanol 
EYFP enhanced yellow fluorescent protein 
FACS Fluorescence activated cell sorting 
FCS fetal calf serum 
FGF fibroblast growth factor 
Fig Figure 
GapDH glyceraldehyde-3-phosphate dehydrogenase 
gDNA genomic desoxyribo nucleic acid 
GFP green fluorescent protein 
GSK3β Glycogen synthase kinase 3 beta 
h hour 
H&E Hematoxylin and Eosin 
HF hair follicle  
HG hair germ 
Hh Hedgehog (Indian-, Sonic-) 
HRP horseradish peroxidase 
i.p. intra peritoneal 
IF immunofluorescence 
IFE interfollicular epidermis 
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Itgα6 Integrin alpha 6 
K keratin 
K2HPO4 Dipotassium phosphate 
kg kilogramm 
Lef1 Lymphoid enhancer-binding factor 1 (LEF1) 
LGR 4 (5, 6) leucine-rich repeat containing G protein-coupled receptor 4 (5,6) 
Lhx2 LIM/homeobox protein Lhx2 
Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 
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LRP Low Density Lipoprotein Receptor-related Proteins 
M molar 
m milli 
MC5R melanocortin 5 receptor 
MeOH methanol 
mg milligramm 
MgCl2 magnesium chloride 
min minute 
mRNA messenger ribonucleic acid 
MTS24 mouse thymic stroma 24 
NBT nitro blue tetrazolium 
NFATc1 nuclear factor of activated T-cells 
NGS normal goat serum 
NGS normal donkey serum 
nt nucleotide 
Nupr1 nuclear protein 1 (P8) 
ORS outer root sheath 
P postnatal day 
PBS phosphate buffered saline 
Pcad P-Cadherin 
PCR polymerase chain reaction 
PFA paraformaldehyde 
Plet1 placenta expressed transcript 1 
pmol picomol 
PNA peptide nucleic acid 
PPARγ peroxisome proliferator-activated receptor gamma 
Prom2 Prominin2 
rpm revolutions per minute 
RT room temperature 
Scd1 Stearoyl CoA-desaturase 1 
SD sebaceous duct 
sec second 
SG sebaceous gland 
sHG secondary hair germ 
Sox9 SRY-box containing gene 9 
TAE Tris-acetate-EDTA 
Tam Tamoxifen 
Tcf3 T-cell factor 3 
TdT Terminal deoxynucleotidyl transferase 
TGFβR Transforming growth factor beta receptor 
UV ultra violet 
V Volt 
WT wild type 
3‘ three prime end of DANN sequence 
5‘ five prime end of DANN sequence 
Δ  deleted / mutated allele 
°C degree Celsius 
µl micro litre 
µm micro metre 
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11) Annex 
 
Table 16) Significantly regulated candidate genes identified by oligunucleotid arrays 
Gene symbol 
Log2fc (compared to 
undifferentied cells) description 
Sebocytes Basal cells 
Elovl4 6,1647 5,1824 elongation of very long chain fatty acids  (FEN1/Elo2, SUR4/Elo3, yeast)-like 4  
Elovl3 5,6606 4,7161 elongation of very long chain fatty acids  (FEN1/Elo2, SUR4/Elo3, yeast)-like 3  
BLAST: Psapl1  4,4094 3,0819 Prosaposin-like 1 
Dhcr24 3,9011 3,1366 24-dehydrocholesterol reductase  
Mxd3 -3,589 -3,3542 Max dimerization protein 3  
Sfxn1 3,5248 3,331 sideroflexin 1  
4632417N05 
Rik BLAST: Sdr42e1 3,4086 - 
short chain dehydrogenase/reductase 
family 42E, member 1 
Adfp 3,3058 1,76 ns adipose differentiation related protein  
Nupr1 3,227 - nuclear protein 1  
BLAST: Echdc1 3,1871 - enoyl Coenzyme A hydratase domain containing 1 
Scd1 3,117 3,5322 stearoyl-Coenzyme A desaturase 1  
Lass4 3,0503 2,3217 ns longevity assurance homolog 4 (S. cerevisiae)  
BLAST: Airn 3,0354 0,0259 antisense Igf2r RNA 
Dgat2l6 3,0271 - diacylglycerol O-acyltransferase 2-like 6 
Cdx2 2,874 2,419 ns caudal type homeo box 2  
Upk1b -2,8714 -1.6053 ns uroplakin 1B  
Pnpla5 2,8461 - patatin-like phospholipase domain containing 5  
Krt79 2,7713 3,4061 keratin 79  
BLAST: Whsc1 -2,7636 -1.,3335 ns Wolf-Hirschhorn syndrome candidate1  
4930422G04 
Rik -2,7279 -1,1666 ns RIKEN cDNA 4930422G04 gene  
BLAST:PERP,  2,7252 3,141 TP53 apoptosis effector 
BLAST: hypothetical 
protein -2,6624 -1,092 ns - 
BLAST: Chr14 genomic 
contig -2,6528 -1,4895 ns - 
Dhrs7 2,6066 2,1764 ns dehydrogenase/reductase (SDR family) member 7  
Zfand2b -2,5674 -1,4192 ns zinc finger, AN1 type domain 2B  
Hmmr -2,5535 -1,3565 ns hyaluronan mediated motility receptor (RHAMM)  
BLAST: Chr6 genomic 
contig -2,52 -1,1593 ns - 
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Psmd10= 
Gankyrin -2,5013 -1,5286 ns 
proteosome (prosome, macropain) 26S 
subunit, non-ATPase, 10  
Ttc3 -2,4928 -1,3378 ns tetratricopeptide repeat domain 3  
Chr12 genomic contig -1,6643 ns -4,3754 - 
BLAST: Prom2 -1,5813 ns n Prominin2 
Cdc123 -1,7725 ns -3,6574 cell division cycle 123 homolog (S. cerevisiae)  
Elovl6 1,5336 ns 3,5222 ELOVL family member 6, elongation of long chain fatty acids (yeast)  
Hbb-b1 -1,2656 ns -3,5128 hemoglobin, beta adult major chain  
Hbb-b2 - -3,3775 Hemoglobin beta minor chain 
Abcb1a -1,4427 ns -3,1921 ATP-binding cassette, sub-family B (MDR/TAP), member 1A  
Ttr - -3,0938 transthyretin  
Apoa2 - -2,9905 apolipoprotein A-II  
2610016E04Rik,BLAST: 
Mup  - -2,9725 
Predicted: Mus musculus similar to Major 
urinary Protein1  
1810011O16Rik - -2,9383 RIKEN cDNA 1810011O16 gene  
Hba-a1 -1,2302 ns -2,8858 hemoglobin alpha, adult chain 1  
- - 2,8661 - 
Alb1 - -2,8545 albumin 1  
Immt 1,6446 ns 2,8526 inner membrane protein, mitochondrial  
Trf - -2,8336 transferrin  
Sftpc -1,1951 ns -2,8333 surfactant associated protein C  
Nrl - -2,8149 neural retina leucine zipper gene  
Hbb-b1 -1,2656 ns -2,77 hemoglobin, beta adult major chain  
Apoa1 - -2,7663 apolipoprotein A-I  
Teddm1 2,0997 ns 2,7459 transmembrane epididymal protein 1  
A430005L14Rik -1,445 ns -2,7371 RIKEN cDNA A430005L14 gene  
Chr2 genomic contig - 2,7309 - 
Hamp1 - -2,6407 hepcidin antimicrobial peptide 1  
Csn3 - -2,6267 casein kappa  
*) ns = not significant; positive values signify up regulation of genes, negative values signify down 
regulation 
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